US5866363A
(en)
|
1985-08-28 |
1999-02-02 |
Pieczenik; George |
Method and means for sorting and identifying biological information
|
US20060008806A1
(en)
*
|
1986-07-17 |
2006-01-12 |
University Of Washington |
Method for producing novel DNA sequence with biological activity
|
US5824469A
(en)
*
|
1986-07-17 |
1998-10-20 |
University Of Washington |
Method for producing novel DNA sequences with biological activity
|
US5266684A
(en)
|
1988-05-02 |
1993-11-30 |
The Reagents Of The University Of California |
Peptide mixtures
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
CA2009996A1
(en)
*
|
1989-02-17 |
1990-08-17 |
Kathleen S. Cook |
Process for making genes encoding random polymers of amino acids
|
US7413537B2
(en)
|
1989-09-01 |
2008-08-19 |
Dyax Corp. |
Directed evolution of disulfide-bonded micro-proteins
|
ATE168416T1
(de)
*
|
1989-10-05 |
1998-08-15 |
Optein Inc |
Zellfreie synthese und isolierung von genen und polypeptiden
|
US5747334A
(en)
*
|
1990-02-15 |
1998-05-05 |
The University Of North Carolina At Chapel Hill |
Random peptide library
|
US5498538A
(en)
*
|
1990-02-15 |
1996-03-12 |
The University Of North Carolina At Chapel Hill |
Totally synthetic affinity reagents
|
EP0515516B1
(en)
*
|
1990-02-15 |
2002-01-16 |
University of North Carolina |
Methods for identifying heterofunctional fusion proteins
|
US5427908A
(en)
*
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
US5639595A
(en)
*
|
1990-05-01 |
1997-06-17 |
Isis Phamaceuticals, Inc. |
Identification of novel drugs and reagents
|
US5811533A
(en)
*
|
1990-06-11 |
1998-09-22 |
Nexstar Pharmaceuticals, Inc. |
High-affinity oligonucleotide ligands to vascular endothelial growth factor (VEGF)
|
US5846713A
(en)
*
|
1990-06-11 |
1998-12-08 |
Nexstar Pharmaceuticals, Inc. |
High affinity HKGF nucleic acid ligands and inhibitors
|
US5864026A
(en)
*
|
1990-06-11 |
1999-01-26 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: tissue selex
|
US5660985A
(en)
|
1990-06-11 |
1997-08-26 |
Nexstar Pharmaceuticals, Inc. |
High affinity nucleic acid ligands containing modified nucleotides
|
US6465188B1
(en)
|
1990-06-11 |
2002-10-15 |
Gilead Sciences, Inc. |
Nucleic acid ligand complexes
|
US5795721A
(en)
*
|
1990-06-11 |
1998-08-18 |
Nexstar Pharmaceuticals, Inc. |
High affinity nucleic acid ligands of ICP4
|
US6177557B1
(en)
|
1990-06-11 |
2001-01-23 |
Nexstar Pharmaceuticals, Inc. |
High affinity ligands of basic fibroblast growth factor and thrombin
|
US5527894A
(en)
*
|
1990-06-11 |
1996-06-18 |
Nexstar Pharmacueticals, Inc. |
Ligands of HIV-1 tat protein
|
US5763566A
(en)
*
|
1990-06-11 |
1998-06-09 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: tissue SELEX
|
US6083696A
(en)
*
|
1990-06-11 |
2000-07-04 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands exponential enrichment: blended selex
|
US5688935A
(en)
*
|
1990-06-11 |
1997-11-18 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligands of tissue target
|
US5459015A
(en)
*
|
1990-06-11 |
1995-10-17 |
Nexstar Pharmaceuticals, Inc. |
High-affinity RNA ligands of basic fibroblast growth factor
|
US6569620B1
(en)
|
1990-06-11 |
2003-05-27 |
Somalogic, Inc. |
Method for the automated generation of nucleic acid ligands
|
US5861254A
(en)
*
|
1997-01-31 |
1999-01-19 |
Nexstar Pharmaceuticals, Inc. |
Flow cell SELEX
|
US6346611B1
(en)
*
|
1990-06-11 |
2002-02-12 |
Gilead Sciences, Inc. |
High affinity TGfβ nucleic acid ligands and inhibitors
|
US5683867A
(en)
*
|
1990-06-11 |
1997-11-04 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: blended SELEX
|
US6261774B1
(en)
|
1990-06-11 |
2001-07-17 |
Gilead Sciences, Inc. |
Truncation selex method
|
US5731424A
(en)
*
|
1990-06-11 |
1998-03-24 |
Nexstar Pharmaceuticals, Inc. |
High affinity TGFβ nucleic acid ligands and inhibitors
|
US5705337A
(en)
*
|
1990-06-11 |
1998-01-06 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: chemi-SELEX
|
US5707796A
(en)
*
|
1990-06-11 |
1998-01-13 |
Nexstar Pharmaceuticals, Inc. |
Method for selecting nucleic acids on the basis of structure
|
US6030776A
(en)
*
|
1990-06-11 |
2000-02-29 |
Nexstar Pharmaceuticals, Inc. |
Parallel SELEX
|
US6696252B2
(en)
|
1990-06-11 |
2004-02-24 |
Gilead Sciences, Inc. |
High-affinity oligonucleotide ligands to vascular endothelial growth factor (VEGF)
|
US5766853A
(en)
*
|
1990-06-11 |
1998-06-16 |
Nexstar Pharmaceuticals, Inc. |
Method for identification of high affinity nucleic acid ligands to selectins
|
US5972599A
(en)
*
|
1990-06-11 |
1999-10-26 |
Nexstar Pharmaceuticals, Inc. |
High affinity nucleic acid ligands of cytokines
|
US5635615A
(en)
*
|
1990-06-11 |
1997-06-03 |
Nexstar Pharmaceuticals, Inc. |
High affinity HIV nucleocapsid nucleic acid ligands
|
US5853984A
(en)
*
|
1990-06-11 |
1998-12-29 |
Nexstar Pharmaceuticals, Inc. |
Use of nucleic acid ligands in flow cytometry
|
US5270163A
(en)
*
|
1990-06-11 |
1993-12-14 |
University Research Corporation |
Methods for identifying nucleic acid ligands
|
US6344321B1
(en)
|
1990-06-11 |
2002-02-05 |
Gilead Sciences, Inc. |
Nucleic acid ligands which bind to hepatocyte growth factor/scatter factor (HGF/SF) or its receptor c-met
|
US5654151A
(en)
*
|
1990-06-11 |
1997-08-05 |
Nexstar Pharmaceuticals, Inc. |
High affinity HIV Nucleocapsid nucleic acid ligands
|
US6232071B1
(en)
|
1990-06-11 |
2001-05-15 |
Gilead Sciences, Inc. |
Tenascin-C nucleic acid ligands
|
US5869641A
(en)
*
|
1990-06-11 |
1999-02-09 |
Nexstar Pharmaceuticals, Inc. |
High affinity nucleic acid ligands of CD4
|
US5763177A
(en)
*
|
1990-06-11 |
1998-06-09 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
|
US6759392B1
(en)
|
1990-06-11 |
2004-07-06 |
Gilead Sciences, Inc. |
High affinity RNA ligands of basic fibroblast growth factor
|
US5668264A
(en)
*
|
1990-06-11 |
1997-09-16 |
Nexstar Pharmaceuticals, Inc. |
High affinity PDGF nucleic acid ligands
|
US6280932B1
(en)
*
|
1990-06-11 |
2001-08-28 |
Gilead Sciences, Inc. |
High affinity nucleic acid ligands to lectins
|
US5874557A
(en)
*
|
1990-06-11 |
1999-02-23 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligand inhibitors to DNA polymerases
|
US5693502A
(en)
*
|
1990-06-11 |
1997-12-02 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligand inhibitors to DNA polymerases
|
US6001577A
(en)
|
1998-06-08 |
1999-12-14 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
|
US5962219A
(en)
*
|
1990-06-11 |
1999-10-05 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: chemi-selex
|
US20040132067A1
(en)
*
|
1990-06-11 |
2004-07-08 |
Somalogic, Inc. |
Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
|
US5849890A
(en)
*
|
1990-06-11 |
1998-12-15 |
Nexstar Pharmaceuticals, Inc. |
High affinity oligonucleotide ligands to chorionic gonadotropin hormone and related glycoprotein hormones
|
US5674685A
(en)
*
|
1990-06-11 |
1997-10-07 |
Nexstar Pharmaceuticals, Inc. |
High affinity PDGF nucleic acid ligands
|
US5750342A
(en)
*
|
1990-06-11 |
1998-05-12 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligands of tissue target
|
US5712375A
(en)
*
|
1990-06-11 |
1998-01-27 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: tissue selex
|
US6610841B1
(en)
|
1997-12-18 |
2003-08-26 |
Gilead Sciences, Inc. |
Nucleotide-based prodrugs
|
US5780228A
(en)
*
|
1990-06-11 |
1998-07-14 |
Nexstar Pharmaceuticals, Inc. |
High affinity nucleic acid ligands to lectins
|
US5756287A
(en)
*
|
1990-06-11 |
1998-05-26 |
Nexstar Pharmaceuticals, Inc. |
High affinity HIV integrase inhibitors
|
US5789163A
(en)
*
|
1990-06-11 |
1998-08-04 |
Nexstar Pharmaceuticals, Inc. |
Enzyme linked oligonucleotide assays (ELONAS)
|
EP0533838B1
(en)
|
1990-06-11 |
1997-12-03 |
NeXstar Pharmaceuticals, Inc. |
Nucleic acid ligands
|
US20060084797A1
(en)
*
|
1990-06-11 |
2006-04-20 |
Gilead Sciences, Inc. |
High affinity TGFbeta nucleic acid ligands and inhibitors
|
US5726017A
(en)
*
|
1990-06-11 |
1998-03-10 |
Nexstar Pharmaceuticals, Inc. |
High affinity HIV-1 gag nucleic acid ligands
|
US5567588A
(en)
*
|
1990-06-11 |
1996-10-22 |
University Research Corporation |
Systematic evolution of ligands by exponential enrichment: Solution SELEX
|
US5496938A
(en)
*
|
1990-06-11 |
1996-03-05 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligands to HIV-RT and HIV-1 rev
|
US5503978A
(en)
*
|
1990-06-11 |
1996-04-02 |
University Research Corporation |
Method for identification of high affinity DNA ligands of HIV-1 reverse transcriptase
|
US5874218A
(en)
*
|
1990-06-11 |
1999-02-23 |
Nexstar Pharmaceuticals, Inc. |
Method for detecting a target compound in a substance using a nucleic acid ligand
|
US5789157A
(en)
*
|
1990-06-11 |
1998-08-04 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: tissue selex
|
US5731144A
(en)
*
|
1990-06-11 |
1998-03-24 |
Nexstar Pharmaceuticals, Inc. |
High affinity TGFβ nucleic acid ligands
|
US5580737A
(en)
*
|
1990-06-11 |
1996-12-03 |
Nexstar Pharmaceuticals, Inc. |
High-affinity nucleic acid ligands that discriminate between theophylline and caffeine
|
US6001988A
(en)
*
|
1990-06-11 |
1999-12-14 |
Nexstar Pharmaceuticals, Inc. |
High affinity nucleic acid ligands to lectins
|
US6331394B1
(en)
|
1991-06-10 |
2001-12-18 |
Gilead Sciences, Inc. |
Nucleic acid ligands to integrins
|
US6011020A
(en)
*
|
1990-06-11 |
2000-01-04 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligand complexes
|
US5648214A
(en)
*
|
1990-06-11 |
1997-07-15 |
University Research Corporation |
High-affinity oligonucleotide ligands to the tachykinin substance P
|
US5686592A
(en)
*
|
1990-06-11 |
1997-11-11 |
Nexstar Pharmaceuticals, Inc. |
High-affinity oligonucleotide ligands to immunoglobulin E (IgE)
|
US6395888B1
(en)
|
1996-02-01 |
2002-05-28 |
Gilead Sciences, Inc. |
High affinity nucleic acid ligands of complement system proteins
|
US5763173A
(en)
*
|
1990-06-11 |
1998-06-09 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligand inhibitors to DNA polymerases
|
US5637682A
(en)
*
|
1990-06-11 |
1997-06-10 |
Nexstar Pharmaceuticals, Inc. |
High-affinity oligonucleotide ligands to the tachykinin substance P
|
US6127119A
(en)
*
|
1990-06-11 |
2000-10-03 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligands of tissue target
|
US5837456A
(en)
*
|
1990-06-11 |
1998-11-17 |
Nexstar Pharmaceuticals, Inc. |
High affinity oligonucleotide ligands to chorionic gonadotropin hormone and related glycoprotein hormones
|
US5641629A
(en)
*
|
1990-06-11 |
1997-06-24 |
Nexstar Pharmacueticals Inc |
Spectroscopically detectable nucleic acid ligands
|
US5472841A
(en)
*
|
1990-06-11 |
1995-12-05 |
Nexstar Pharmaceuticals, Inc. |
Methods for identifying nucleic acid ligands of human neutrophil elastase
|
US6140490A
(en)
*
|
1996-02-01 |
2000-10-31 |
Nexstar Pharmaceuticals, Inc. |
High affinity nucleic acid ligands of complement system proteins
|
US6465189B1
(en)
|
1990-06-11 |
2002-10-15 |
Gilead Sciences, Inc. |
Systematic evolution of ligands by exponential enrichment: blended selex
|
US6716580B2
(en)
|
1990-06-11 |
2004-04-06 |
Somalogic, Inc. |
Method for the automated generation of nucleic acid ligands
|
US5723289A
(en)
*
|
1990-06-11 |
1998-03-03 |
Nexstar Pharmaceuticals, Inc. |
Parallel selex
|
US5837834A
(en)
*
|
1990-06-11 |
1998-11-17 |
Nexstar Pharmaceuticals, Inc. |
High affinity HKGF nucleic acid ligands and inhibitors
|
US5637459A
(en)
*
|
1990-06-11 |
1997-06-10 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: chimeric selex
|
US5587468A
(en)
*
|
1990-06-11 |
1996-12-24 |
University Research Corporation |
High affinity nucleic acid ligands to HIV integrase
|
US6124449A
(en)
*
|
1990-06-11 |
2000-09-26 |
Nexstar Pharmaceuticals, Inc. |
High affinity TGFβ nucleic acid ligands and inhibitors
|
US5629155A
(en)
*
|
1990-06-11 |
1997-05-13 |
Nexstar Pharmaceuticals, Inc. |
High-affinity oligonucleotide ligands to immunoglobulin E (IgE)
|
US5543293A
(en)
*
|
1990-06-11 |
1996-08-06 |
Nexstar Pharmaceuticals, Inc. |
DNA ligands of thrombin
|
US5723286A
(en)
*
|
1990-06-20 |
1998-03-03 |
Affymax Technologies N.V. |
Peptide library and screening systems
|
US6916605B1
(en)
|
1990-07-10 |
2005-07-12 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
US7063943B1
(en)
|
1990-07-10 |
2006-06-20 |
Cambridge Antibody Technology |
Methods for producing members of specific binding pairs
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
US5843701A
(en)
*
|
1990-08-02 |
1998-12-01 |
Nexstar Pharmaceticals, Inc. |
Systematic polypeptide evolution by reverse translation
|
DK1279731T3
(da)
|
1991-03-01 |
2007-09-24 |
Dyax Corp |
Fremgangsmåde til udvikling af bindende miniproteiner
|
US6762290B1
(en)
*
|
1999-07-29 |
2004-07-13 |
Gilead Sciences, Inc. |
High affinity vascular endothelial growth factor (VEGF) receptor nucleic acid ligands and inhibitors
|
US6028186A
(en)
*
|
1991-06-10 |
2000-02-22 |
Nexstar Pharmaceuticals, Inc. |
High affinity nucleic acid ligands of cytokines
|
AU2313392A
(en)
*
|
1991-08-01 |
1993-03-02 |
University Research Corporation |
Systematic polypeptide evolution by reverse translation
|
US5733731A
(en)
*
|
1991-10-16 |
1998-03-31 |
Affymax Technologies N.V. |
Peptide library and screening method
|
US5270170A
(en)
*
|
1991-10-16 |
1993-12-14 |
Affymax Technologies N.V. |
Peptide library and screening method
|
ATE275198T1
(de)
|
1991-12-02 |
2004-09-15 |
Medical Res Council |
Herstellung von antikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken.
|
US5656467A
(en)
*
|
1992-01-09 |
1997-08-12 |
The Trustees Of The University Of Pennsylvania |
Methods and materials for producing gene libraries
|
WO1993019170A1
(en)
*
|
1992-03-16 |
1993-09-30 |
Jacob Nathaniel Wohlstadter |
Selection methods
|
US5869644A
(en)
*
|
1992-04-15 |
1999-02-09 |
The Johns Hopkins University |
Synthesis of diverse and useful collections of oligonucleotidies
|
US5719273A
(en)
*
|
1993-06-14 |
1998-02-17 |
Nexstar Pharmaceuticals, Inc. |
Palladium catalyzed nucleoside modifications methods using nucleophiles and carbon monoxide
|
US5998142A
(en)
*
|
1993-09-08 |
1999-12-07 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: chemi-SELEX
|
US6458539B1
(en)
|
1993-09-17 |
2002-10-01 |
Somalogic, Inc. |
Photoselection of nucleic acid ligands
|
WO1995010296A1
(en)
*
|
1993-10-12 |
1995-04-20 |
Glycomed Incorporated |
A library of glyco-peptides useful for identification of cell adhesion inhibitors
|
US20060078561A1
(en)
*
|
1994-01-31 |
2006-04-13 |
The Trustees Of Boston University |
Polyclonal antibody libraries
|
PT1231268E
(pt)
|
1994-01-31 |
2005-11-30 |
Univ Boston |
Bancos de anticorpos policlonais
|
US6165793A
(en)
*
|
1996-03-25 |
2000-12-26 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
US5837458A
(en)
|
1994-02-17 |
1998-11-17 |
Maxygen, Inc. |
Methods and compositions for cellular and metabolic engineering
|
US6309883B1
(en)
|
1994-02-17 |
2001-10-30 |
Maxygen, Inc. |
Methods and compositions for cellular and metabolic engineering
|
US6335160B1
(en)
|
1995-02-17 |
2002-01-01 |
Maxygen, Inc. |
Methods and compositions for polypeptide engineering
|
US20060257890A1
(en)
|
1996-05-20 |
2006-11-16 |
Maxygen, Inc. |
Methods and compositions for cellular and metabolic engineering
|
US6995017B1
(en)
|
1994-02-17 |
2006-02-07 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
US6117679A
(en)
|
1994-02-17 |
2000-09-12 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
US6406855B1
(en)
|
1994-02-17 |
2002-06-18 |
Maxygen, Inc. |
Methods and compositions for polypeptide engineering
|
US6395547B1
(en)
|
1994-02-17 |
2002-05-28 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
US5605793A
(en)
|
1994-02-17 |
1997-02-25 |
Affymax Technologies N.V. |
Methods for in vitro recombination
|
US7153948B2
(en)
|
1994-04-25 |
2006-12-26 |
Gilead Sciences, Inc. |
High-affinity oligonucleotide ligands to vascular endothelial growth factor (VEGF)
|
US6682886B1
(en)
|
1994-04-28 |
2004-01-27 |
Gilead Sciences, Inc. |
Bivalent binding molecules of 7 transmembrane G protein-coupled receptors
|
US6010861A
(en)
*
|
1994-08-03 |
2000-01-04 |
Dgi Biotechnologies, Llc |
Target specific screens and their use for discovering small organic molecular pharmacophores
|
US6048698A
(en)
*
|
1994-09-20 |
2000-04-11 |
Nexstar Pharmaceuticals, Inc. |
Parallel SELEX™
|
DE69526665T2
(de)
*
|
1994-09-21 |
2002-11-21 |
Cytogen Corp |
Antigen bindende peptide (abtides) aus peptidbibliotheken
|
US5885577A
(en)
*
|
1994-09-21 |
1999-03-23 |
Cytogen Corporation |
Antigen binding peptides (abtides) from peptide libraries
|
AU732961B2
(en)
*
|
1995-05-03 |
2001-05-03 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: tissue selex
|
US6013443A
(en)
|
1995-05-03 |
2000-01-11 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: tissue SELEX
|
US8071737B2
(en)
|
1995-05-04 |
2011-12-06 |
Glead Sciences, Inc. |
Nucleic acid ligand complexes
|
US5859228A
(en)
*
|
1995-05-04 |
1999-01-12 |
Nexstar Pharmaceuticals, Inc. |
Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes
|
WO1996038579A1
(en)
|
1995-06-02 |
1996-12-05 |
Nexstar Pharmaceuticals, Inc. |
High-affinity oligonucleotide ligands to growth factors
|
US20010053523A1
(en)
*
|
1995-06-02 |
2001-12-20 |
M&E Biotech A/S. |
Method for identification of biologically active peptides and nucleic acids
|
US5723594A
(en)
*
|
1995-06-07 |
1998-03-03 |
Nexstar Pharmaceuticals, Inc. |
High affinity PDGF nucleic acid ligands
|
US6475806B1
(en)
|
1995-06-07 |
2002-11-05 |
Praecis Pharmaceuticals, Inc. |
Anchor libraries and identification of peptide binding sequences
|
DK0833944T3
(da)
*
|
1995-06-07 |
2009-05-11 |
Gilead Sciences Inc |
Nucleinsyreligander som binder til og inhiberer DNA-polymeraser
|
US6229002B1
(en)
|
1995-06-07 |
2001-05-08 |
Nexstar Pharmaceuticlas, Inc. |
Platelet derived growth factor (PDGF) nucleic acid ligand complexes
|
US5797870A
(en)
*
|
1995-06-07 |
1998-08-25 |
Indiana University Foundation |
Pericardial delivery of therapeutic and diagnostic agents
|
US20090118481A1
(en)
*
|
1995-06-07 |
2009-05-07 |
Gilead Sciences, Inc. |
High Affinity Nucleic Acid Ligands To Lectins
|
US6699843B2
(en)
|
1995-06-07 |
2004-03-02 |
Gilead Sciences, Inc. |
Method for treatment of tumors using nucleic acid ligands to PDGF
|
US6183967B1
(en)
|
1995-06-07 |
2001-02-06 |
Nexstar Pharmaceuticals |
Nucleic acid ligand inhibitors to DNA polymerases
|
US6361974B1
(en)
|
1995-12-07 |
2002-03-26 |
Diversa Corporation |
Exonuclease-mediated nucleic acid reassembly in directed evolution
|
US6358709B1
(en)
|
1995-12-07 |
2002-03-19 |
Diversa Corporation |
End selection in directed evolution
|
US6740506B2
(en)
|
1995-12-07 |
2004-05-25 |
Diversa Corporation |
End selection in directed evolution
|
US5830696A
(en)
|
1996-12-05 |
1998-11-03 |
Diversa Corporation |
Directed evolution of thermophilic enzymes
|
US7018793B1
(en)
*
|
1995-12-07 |
2006-03-28 |
Diversa Corporation |
Combinatorial screening of mixed populations of organisms
|
US5965408A
(en)
|
1996-07-09 |
1999-10-12 |
Diversa Corporation |
Method of DNA reassembly by interrupting synthesis
|
US6939689B2
(en)
|
1995-12-07 |
2005-09-06 |
Diversa Corporation |
Exonuclease-mediated nucleic acid reassembly in directed evolution
|
US20020028443A1
(en)
*
|
1999-09-27 |
2002-03-07 |
Jay M. Short |
Method of dna shuffling with polynucleotides produced by blocking or interrupting a synthesis or amplification process
|
US6713279B1
(en)
|
1995-12-07 |
2004-03-30 |
Diversa Corporation |
Non-stochastic generation of genetic vaccines and enzymes
|
US20020164580A1
(en)
*
|
1995-12-07 |
2002-11-07 |
Diversa Corporation |
Combinatorial screening of mixed populations of organisms
|
US6537776B1
(en)
|
1999-06-14 |
2003-03-25 |
Diversa Corporation |
Synthetic ligation reassembly in directed evolution
|
US6352842B1
(en)
|
1995-12-07 |
2002-03-05 |
Diversa Corporation |
Exonucease-mediated gene assembly in directed evolution
|
US20030219752A1
(en)
*
|
1995-12-07 |
2003-11-27 |
Diversa Corporation |
Novel antigen binding molecules for therapeutic, diagnostic, prophylactic, enzymatic, industrial, and agricultural applications, and methods for generating and screening thereof
|
US6365344B1
(en)
|
1996-01-23 |
2002-04-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for screening for transdominant effector peptides and RNA molecules
|
DK0877752T3
(da)
|
1996-01-23 |
2003-09-15 |
Univ Leland Stanford Junior |
Fremgangsmåder til screening af transdominante effektorpeptider og RNA molekyler
|
US6096548A
(en)
|
1996-03-25 |
2000-08-01 |
Maxygen, Inc. |
Method for directing evolution of a virus
|
US6506602B1
(en)
|
1996-03-25 |
2003-01-14 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
US6699658B1
(en)
|
1996-05-31 |
2004-03-02 |
Board Of Trustees Of The University Of Illinois |
Yeast cell surface display of proteins and uses thereof
|
US6696251B1
(en)
|
1996-05-31 |
2004-02-24 |
Board Of Trustees Of The University Of Illinois |
Yeast cell surface display of proteins and uses thereof
|
US6300065B1
(en)
|
1996-05-31 |
2001-10-09 |
Board Of Trustees Of The University Of Illinois |
Yeast cell surface display of proteins and uses thereof
|
US6838238B1
(en)
|
1996-10-17 |
2005-01-04 |
Invitrogen Corporation |
Morphatides: novel shape and structure libraries
|
US6426335B1
(en)
*
|
1997-10-17 |
2002-07-30 |
Gilead Sciences, Inc. |
Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes
|
JP2001504328A
(ja)
|
1996-10-31 |
2001-04-03 |
スミスクライン・ビーチャム・コーポレイション |
医薬上使用される化合物と結合するrna標的モチーフの特徴付けおよび選択の方法
|
US20070009930A1
(en)
*
|
1996-12-18 |
2007-01-11 |
Maxygen, Inc. |
Methods and compositions for polypeptide engineering
|
IL130635A0
(en)
|
1997-01-17 |
2000-06-01 |
Maxygen Inc |
Evolution of whole cells and organisms by recursive sequence recombination
|
US6326204B1
(en)
|
1997-01-17 |
2001-12-04 |
Maxygen, Inc. |
Evolution of whole cells and organisms by recursive sequence recombination
|
US7148054B2
(en)
*
|
1997-01-17 |
2006-12-12 |
Maxygen, Inc. |
Evolution of whole cells and organisms by recursive sequence recombination
|
US6261804B1
(en)
*
|
1997-01-21 |
2001-07-17 |
The General Hospital Corporation |
Selection of proteins using RNA-protein fusions
|
AU738328B2
(en)
|
1997-01-21 |
2001-09-13 |
General Hospital Corporation, The |
Selection of proteins using RNA-protein fusions
|
US8207093B2
(en)
*
|
1997-01-21 |
2012-06-26 |
The General Hospital Corporation |
Selection of proteins using RNA-protein fusions
|
US5871924A
(en)
*
|
1997-01-27 |
1999-02-16 |
Nexstar Pharmaceuticals, Inc. |
Method for the production of ligands capable of facilitating aminoacyl-RNA synthesis
|
US6153410A
(en)
*
|
1997-03-25 |
2000-11-28 |
California Institute Of Technology |
Recombination of polynucleotide sequences using random or defined primers
|
US6180341B1
(en)
|
1997-05-01 |
2001-01-30 |
Board Of Regents, The Universiry Of Texas System |
In vitro scanning saturation mutagenesis of proteins
|
US7087420B1
(en)
|
1997-07-17 |
2006-08-08 |
Cambia |
Microbial β-glucuronidase genes, gene products and uses thereof
|
US6391547B1
(en)
*
|
1997-09-09 |
2002-05-21 |
Center For The Application Of Molecular Biology To International Agriculture |
Microbial β-glucuronidase genes, gene products and uses thereof
|
US6241701B1
(en)
|
1997-08-01 |
2001-06-05 |
Genetronics, Inc. |
Apparatus for electroporation mediated delivery of drugs and genes
|
US6670127B2
(en)
|
1997-09-16 |
2003-12-30 |
Egea Biosciences, Inc. |
Method for assembly of a polynucleotide encoding a target polypeptide
|
EP1690868A1
(en)
|
1997-10-31 |
2006-08-16 |
Maxygen, Inc. |
Modification of virus tropism and host range by viral genome shuffling
|
CA2313380C
(en)
|
1997-12-08 |
2008-12-30 |
California Institute Of Technology |
Method for creating polynucleotide and polypeptide sequences
|
US5989823A
(en)
*
|
1998-09-18 |
1999-11-23 |
Nexstar Pharmaceuticals, Inc. |
Homogeneous detection of a target through nucleic acid ligand-ligand beacon interaction
|
EP1049803A4
(en)
|
1997-12-15 |
2002-08-21 |
Nexstar Pharmaceuticals Inc |
HOMOGENEOUS DETECTION OF TARGET MOLECULES BY LIGAND NUCLEIC ACID AND LIGAND BEACON INTERACTION
|
US20070166741A1
(en)
|
1998-12-14 |
2007-07-19 |
Somalogic, Incorporated |
Multiplexed analyses of test samples
|
US20030219803A1
(en)
*
|
1997-12-15 |
2003-11-27 |
Somalogic, Incorporated |
Homogeneous detection of a target through nucleic acid ligand-ligand beacon interaction
|
WO2003070984A1
(en)
|
2002-02-15 |
2003-08-28 |
Somalogic, Inc. |
Methods and reagents for detecting target binding by nucleic acid ligands
|
US6759243B2
(en)
|
1998-01-20 |
2004-07-06 |
Board Of Trustees Of The University Of Illinois |
High affinity TCR proteins and methods
|
US6541011B2
(en)
*
|
1998-02-11 |
2003-04-01 |
Maxygen, Inc. |
Antigen library immunization
|
US7390619B1
(en)
*
|
1998-02-11 |
2008-06-24 |
Maxygen, Inc. |
Optimization of immunomodulatory properties of genetic vaccines
|
FR2782325B1
(fr)
*
|
1998-08-12 |
2002-05-24 |
Proteus |
Procede d'identification de sequences polynucleotidiques et/ou des proteines correspondantes a partir d'un echantillon d'acides nucleiques
|
US7157083B2
(en)
*
|
1998-04-17 |
2007-01-02 |
Surrogate Pharmaceutical Pathways, Llc |
Compositions and methods for treating retroviral infections
|
BR9910174A
(pt)
|
1998-05-01 |
2001-03-06 |
Maxygen Inc |
Processo para se obter um gene recombinante otimizado de resistência à praga, biblioteca, e, processo para se obter um organismo que seja patogênico a uma praga de vegetal
|
US7153655B2
(en)
*
|
1998-06-16 |
2006-12-26 |
Alligator Bioscience Ab |
Method for in vitro molecular evolution of protein function involving the use of exonuclease enzyme and two populations of parent polynucleotide sequence
|
US6365408B1
(en)
|
1998-06-19 |
2002-04-02 |
Maxygen, Inc. |
Methods of evolving a polynucleotides by mutagenesis and recombination
|
WO2000006717A2
(en)
|
1998-07-27 |
2000-02-10 |
Genentech, Inc. |
Improved transformation efficiency in phage display through modification of a coat protein
|
DE69941193D1
(de)
|
1998-08-17 |
2009-09-10 |
Bristol Myers Squibb Co |
Identifizierung von verbindung-protein wechselwirkungen mit bibliotheken von gekoppelten protein-nukleinsäure-molekülen
|
US6773911B1
(en)
*
|
1998-11-23 |
2004-08-10 |
Amgen Canada Inc. |
Apoptosis-inducing factor
|
US6570003B1
(en)
*
|
2001-01-09 |
2003-05-27 |
Lexion Genetics Incorporated |
Human 7TM proteins and polynucleotides encoding the same
|
EP1141275B1
(en)
*
|
1999-01-05 |
2009-08-12 |
Trustees Of Boston University |
Improved nucleic acid cloning
|
EP1151409A1
(en)
*
|
1999-01-18 |
2001-11-07 |
Maxygen, Inc. |
Methods of populating data stuctures for use in evolutionary simulations
|
US20030054390A1
(en)
*
|
1999-01-19 |
2003-03-20 |
Maxygen, Inc. |
Oligonucleotide mediated nucleic acid recombination
|
US20070065838A1
(en)
*
|
1999-01-19 |
2007-03-22 |
Maxygen, Inc. |
Oligonucleotide mediated nucleic acid recombination
|
US20030054360A1
(en)
*
|
1999-01-19 |
2003-03-20 |
Larry Gold |
Method and apparatus for the automated generation of nucleic acid ligands
|
US20090130718A1
(en)
*
|
1999-02-04 |
2009-05-21 |
Diversa Corporation |
Gene site saturation mutagenesis
|
US6329145B1
(en)
|
1999-02-09 |
2001-12-11 |
Gilead Science, Inc. |
Determining non-nucleic acid molecule binding to target by competition with nucleic acid ligand
|
EP1165775A2
(en)
|
1999-03-05 |
2002-01-02 |
Maxygen, Inc. |
Recombination of insertion modified nucleic acids
|
US6703240B1
(en)
|
1999-04-13 |
2004-03-09 |
Maxygar, Inc. |
Modified starch metabolism enzymes and encoding genes for improvement and optimization of plant phenotypes
|
US7332308B1
(en)
|
1999-05-21 |
2008-02-19 |
The Penn State Research Foundation |
Incrementally truncated nucleic acids and methods of making same
|
US6280943B1
(en)
*
|
1999-06-17 |
2001-08-28 |
Gilead Sciences, Inc. |
2′-fluoropyrimidine anti-calf intestinal phosphatase nucleic acid ligands
|
EP1860188B1
(en)
|
1999-07-07 |
2011-05-04 |
ZymoGenetics, Inc. |
Human cytokine receptor
|
US6387620B1
(en)
*
|
1999-07-28 |
2002-05-14 |
Gilead Sciences, Inc. |
Transcription-free selex
|
US7005260B1
(en)
|
2000-01-28 |
2006-02-28 |
Gilead Sciences, Inc. |
Tenascin-C nucleic acid ligands
|
DE60042021D1
(de)
*
|
1999-07-29 |
2009-05-28 |
Gilead Sciences Inc |
Nukleinsäureliganden für den hepatozytischen wachstumsfaktor/dispersionsfaktor (hgf/sf) und seines c-met rezeptors
|
US6506887B1
(en)
|
1999-07-29 |
2003-01-14 |
Somalogic, Incorporated |
Conditional-selex
|
US6171795B1
(en)
|
1999-07-29 |
2001-01-09 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligands to CD40ligand
|
US6734009B2
(en)
*
|
2000-12-27 |
2004-05-11 |
Lexicon Genetics Incorporated |
Human kinases and polynucleotides encoding the same
|
US6797510B1
(en)
*
|
2001-05-24 |
2004-09-28 |
Lexicon Genetics Incorporated |
Human kinases and polynucleotides encoding the same
|
US6586230B1
(en)
|
2000-10-27 |
2003-07-01 |
Lexicon Genetics Incorporated |
Human kinase and polynucleotides encoding the same
|
US20080050809A1
(en)
*
|
1999-09-28 |
2008-02-28 |
Alejandro Abuin |
Novel human kinases and polynucleotides encoding the same
|
US6541252B1
(en)
|
2000-05-19 |
2003-04-01 |
Lexicon Genetics Incorporated |
Human kinases and polynucleotides encoding the same
|
US6841377B1
(en)
|
2001-06-13 |
2005-01-11 |
Lexicon Genetics Incorporated |
Human kinase and polynucleotides encoding the same
|
US6900045B2
(en)
*
|
2000-08-31 |
2005-05-31 |
Lexicon Genetics Incorporated |
Human kinase proteins and polynucleotides encoding the same
|
US6849425B1
(en)
|
1999-10-14 |
2005-02-01 |
Ixsys, Inc. |
Methods of optimizing antibody variable region binding affinity
|
IL149809A0
(en)
*
|
1999-12-15 |
2002-11-10 |
Genentech Inc |
Shotgun scanning, a combinatorial method for mapping functional protein epitopes
|
US7022479B2
(en)
*
|
2000-01-24 |
2006-04-04 |
Compound Therapeutics, Inc. |
Sensitive, multiplexed diagnostic assays for protein analysis
|
DE60118527D1
(de)
|
2000-01-24 |
2006-05-18 |
Compound Therapeutics Inc |
Sensible und multiplexe diagnostische tests zur proteinanalyse
|
AU2001253117B8
(en)
*
|
2000-01-26 |
2006-08-03 |
Lexicon Pharmaceuticals, Inc. |
Human neurexin-like proteins and polynucleotides encoding the same
|
US20050239061A1
(en)
*
|
2000-03-01 |
2005-10-27 |
Marshall William S |
Identification and use of effectors and allosteric molecules for the alteration of gene expression
|
US7514239B2
(en)
|
2000-03-28 |
2009-04-07 |
Amgen Inc. |
Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptides and heterodimers thereof
|
WO2001075178A2
(en)
*
|
2000-04-04 |
2001-10-11 |
Enanta Pharmaceuticals, Inc. |
Methods for identifying peptide aptamers capable of altering a cell phenotype
|
CA2406236C
(en)
*
|
2000-04-17 |
2013-02-19 |
Dyax Corp. |
Novel methods of constructing libraries of genetic packages that collectively display the members of a diverse family of peptides, polypeptides or proteins
|
US8288322B2
(en)
|
2000-04-17 |
2012-10-16 |
Dyax Corp. |
Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries
|
AU2001257091A1
(en)
*
|
2000-04-18 |
2001-10-30 |
Gilead Sciences, Inc. |
Aptamer based two-site binding assay
|
US6479262B1
(en)
|
2000-05-16 |
2002-11-12 |
Hercules, Incorporated |
Solid phase enzymatic assembly of polynucleotides
|
WO2001090179A2
(en)
*
|
2000-05-23 |
2001-11-29 |
Lexicon Genetics Incorporated |
Novel human thrombospondin-like proteins and polynucleotides encoding the same
|
AU2001275337A1
(en)
*
|
2000-06-07 |
2001-12-17 |
Lexicon Genetics Incorporated |
Novel human transporter proteins and polynucleotides encoding the same
|
WO2001094417A2
(en)
*
|
2000-06-09 |
2001-12-13 |
Lexicon Genetics Incorporated |
Novel human seven transmembrane proteins and polynucleotides encoding the same
|
US6465632B1
(en)
|
2000-06-09 |
2002-10-15 |
Lexicon Genetics Incorporated |
Human phosphatases and polynucleotides encoding the same
|
ES2391124T3
(es)
|
2000-06-28 |
2012-11-21 |
Amgen Inc. |
Moléculas de receptor de linfopoyetina estromal tímica y usos de las mismas
|
US6994963B1
(en)
|
2000-07-10 |
2006-02-07 |
Ambion, Inc. |
Methods for recombinatorial nucleic acid synthesis
|
JP2004504330A
(ja)
*
|
2000-07-13 |
2004-02-12 |
インヴィトロジェン コーポレーション |
溶解マトリクスを用いてタンパク質およびペプチドの迅速な抽出および単離のための方法および組成物
|
US20030017552A1
(en)
*
|
2000-07-21 |
2003-01-23 |
Jarrell Kevin A. |
Modular vector systems
|
WO2002010183A1
(en)
*
|
2000-07-31 |
2002-02-07 |
Menzel, Rolf |
Compositions and methods for directed gene assembly
|
CA2417240A1
(en)
*
|
2000-08-07 |
2002-02-14 |
Sloan-Kettering Institute For Cancer Research |
Method and composition for immunization using mixed pools of mutated nucleic acids or peptides
|
UA81743C2
(uk)
|
2000-08-07 |
2008-02-11 |
Центокор, Инк. |
МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ
|
US6902734B2
(en)
|
2000-08-07 |
2005-06-07 |
Centocor, Inc. |
Anti-IL-12 antibodies and compositions thereof
|
US7288390B2
(en)
|
2000-08-07 |
2007-10-30 |
Centocor, Inc. |
Anti-dual integrin antibodies, compositions, methods and uses
|
JP2004506447A
(ja)
*
|
2000-08-22 |
2004-03-04 |
レキシコン・ジェネティクス・インコーポレーテッド |
新規ヒト7tmタンパクおよびそれをコードするポリヌクレオチド
|
US6376190B1
(en)
|
2000-09-22 |
2002-04-23 |
Somalogic, Inc. |
Modified SELEX processes without purified protein
|
WO2002026932A2
(en)
*
|
2000-09-26 |
2002-04-04 |
Duke University |
Rna aptamers and methods for identifying the same
|
AU2002211624A1
(en)
*
|
2000-10-10 |
2002-04-22 |
Genencor International, Inc. |
Information rich libraries
|
JP4176466B2
(ja)
|
2000-10-16 |
2008-11-05 |
ギリード・サイエンシズ・インコーポレーテッド |
前立腺特異的膜抗原に対する核酸リガンド
|
WO2002070705A2
(en)
*
|
2000-10-27 |
2002-09-12 |
Lexicon Genetics Incorporated |
Human 7tm proteins and polynucleotides encoding them
|
JP2004531209A
(ja)
*
|
2000-10-30 |
2004-10-14 |
レキシコン・ジェネティクス・インコーポレーテッド |
新規ヒト7tmタンパクおよびそれをコードするポリヌクレオチド
|
WO2002042438A2
(en)
|
2000-11-20 |
2002-05-30 |
Lexicon Genetics Incorporated |
Human kinases and polynucleotides encoding the same
|
US20020165149A1
(en)
*
|
2000-12-08 |
2002-11-07 |
Kranz David M. |
Mutated class II major histocompatibility proteins
|
CA2431007A1
(en)
*
|
2000-12-11 |
2002-07-18 |
Lexicon Genetics Incorporated |
Novel human kinase and polynucleotides encoding the same
|
US6958213B2
(en)
|
2000-12-12 |
2005-10-25 |
Alligator Bioscience Ab |
Method for in vitro molecular evolution of protein function
|
AU3264202A
(en)
*
|
2000-12-12 |
2002-06-24 |
Lexicon Genetics Inc |
Novel human kinases and polynucleotides encoding the same
|
PT2316940E
(pt)
|
2000-12-18 |
2013-10-16 |
Dyax Corp |
Bibliotecas orientadas de pacotes genéticos
|
US6852844B1
(en)
*
|
2000-12-20 |
2005-02-08 |
Lexicon Genetics Incorporated |
Human protocadherin proteins and polynucleotides encoding the same
|
US20020086292A1
(en)
|
2000-12-22 |
2002-07-04 |
Shigeaki Harayama |
Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide molecules
|
WO2002051438A2
(en)
|
2000-12-22 |
2002-07-04 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Use of repulsive guidance molecule (rgm) and its modulators
|
JP4061043B2
(ja)
|
2000-12-28 |
2008-03-12 |
株式会社ポストゲノム研究所 |
invitro転写/翻訳系によるペプチド等の製造方法
|
CA2434896A1
(en)
*
|
2001-01-23 |
2002-08-01 |
Lexicon Genetics Incorporated |
Novel human kinases and polynucleotides encoding the same
|
US7582423B2
(en)
*
|
2001-02-02 |
2009-09-01 |
Novici Biotech Llc |
Population of polynucleotide sequence variants
|
US20040142433A1
(en)
*
|
2001-02-02 |
2004-07-22 |
Padgett Hal S. |
Polynucleotide sequence variants
|
CA2436214C
(en)
|
2001-02-02 |
2012-12-04 |
Large Scale Biology Corporation |
A method of increasing complementarity in a heteroduplex polynucleotide
|
US7838219B2
(en)
*
|
2001-02-02 |
2010-11-23 |
Novici Biotech Llc |
Method of increasing complementarity in a heteroduplex
|
US20020127587A1
(en)
*
|
2001-02-13 |
2002-09-12 |
Domenica Simms |
Methods and compositions for isolation of biological macromolecules
|
WO2002068630A1
(en)
*
|
2001-02-22 |
2002-09-06 |
Praecis Pharmaceuticals Incorporated |
Methods for identifying peptides which modulate a biological process
|
AU2002305944A1
(en)
|
2001-03-02 |
2002-09-19 |
Zymogenetics, Inc. |
Mouse cytokine receptor
|
US7807408B2
(en)
*
|
2001-03-19 |
2010-10-05 |
President & Fellows Of Harvard College |
Directed evolution of proteins
|
WO2002074978A2
(en)
|
2001-03-19 |
2002-09-26 |
President And Fellows Of Harvard College |
Nucleic acid shuffling
|
WO2002074932A2
(en)
|
2001-03-20 |
2002-09-26 |
Lexicon Genetics Incorporated |
Novel human kinase and polynucleotides encoding the same
|
EP1383880A1
(en)
|
2001-04-06 |
2004-01-28 |
Lexicon Genetics Incorporated |
Novel human kinase and polynucleotides encoding the same
|
CA2443516A1
(en)
|
2001-04-06 |
2002-10-17 |
Lexicon Genetics Incorporated |
Novel human kinases and polynucleotides encoding the same
|
US6644173B2
(en)
*
|
2001-04-11 |
2003-11-11 |
Keuring, Incorporated |
Beverage filter cartridge holder
|
EP1383887A4
(en)
*
|
2001-05-03 |
2004-07-07 |
Rensselaer Polytech Inst |
NEW DIRECTED EVOLUTION METHODS
|
CA2446967A1
(en)
*
|
2001-05-09 |
2002-11-14 |
Lexicon Genetics Incorporated |
Novel human kinases and polynucleotides encoding the same
|
CA2448567C
(en)
*
|
2001-05-25 |
2014-05-20 |
Duke University |
Modulators of nucleic acid ligands
|
WO2002097095A1
(en)
*
|
2001-05-25 |
2002-12-05 |
Lexicon Genetics Incorporated |
Novel human transporter proteins and polynucleotides encoding the same
|
US6867025B2
(en)
|
2001-05-29 |
2005-03-15 |
Lexicon Genetics Incorporated |
Human hydroxylases and polynucleotides encoding the same
|
US20060270003A1
(en)
|
2003-07-08 |
2006-11-30 |
Genentech, Inc. |
IL-17A/F heterologous polypeptides and therapeutic uses thereof
|
US20030113714A1
(en)
*
|
2001-09-28 |
2003-06-19 |
Belcher Angela M. |
Biological control of nanoparticles
|
US20030148380A1
(en)
*
|
2001-06-05 |
2003-08-07 |
Belcher Angela M. |
Molecular recognition of materials
|
US20050164515A9
(en)
*
|
2001-06-05 |
2005-07-28 |
Belcher Angela M. |
Biological control of nanoparticle nucleation, shape and crystal phase
|
US20070160576A1
(en)
|
2001-06-05 |
2007-07-12 |
Genentech, Inc. |
IL-17A/F heterologous polypeptides and therapeutic uses thereof
|
CA2633171C
(en)
|
2001-06-20 |
2012-11-20 |
Genentech, Inc. |
Antibodies against tumor-associated antigenic target (tat) polypeptides
|
DE10131441A1
(de)
*
|
2001-06-29 |
2003-01-30 |
Henkel Kgaa |
Eine neue Gruppe von alpha-Amylasen sowie ein Verfahren zur Identifizierung und Gewinnung neuer alpha-Amylasen
|
US20040204669A1
(en)
*
|
2001-07-05 |
2004-10-14 |
Hofmann Gunter A. |
Apparatus for electroporation mediated delivery for drugs and genes
|
JP2004533840A
(ja)
*
|
2001-07-06 |
2004-11-11 |
ジェネンテック・インコーポレーテッド |
ファージディスプレイによるpdzドメインリガンド
|
US6943001B2
(en)
*
|
2001-08-03 |
2005-09-13 |
Diversa Corporation |
Epoxide hydrolases, nucleic acids encoding them and methods for making and using them
|
WO2003012126A2
(en)
*
|
2001-08-03 |
2003-02-13 |
Diversa Corporation |
Epoxide hydrolases, nucleic acids encoding them and methods for making and using them
|
DE10138753B4
(de)
*
|
2001-08-07 |
2017-07-20 |
Henkel Ag & Co. Kgaa |
Wasch- und Reinigungsmittel mit Hybrid-Alpha-Amylasen
|
US7647184B2
(en)
*
|
2001-08-27 |
2010-01-12 |
Hanall Pharmaceuticals, Co. Ltd |
High throughput directed evolution by rational mutagenesis
|
NZ573831A
(en)
|
2001-09-18 |
2010-07-30 |
Genentech Inc |
Compositions and methods for the diagnosis and treatment of tumor, particularly breast tumor - TAT193
|
ES2327905T3
(es)
*
|
2001-10-01 |
2009-11-05 |
Dyax Corp. |
Vectores de presentacion eucariotas multi-cadena y usos de los mismos.
|
US20030073104A1
(en)
*
|
2001-10-02 |
2003-04-17 |
Belcher Angela M. |
Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus
|
EP1840211A1
(en)
|
2001-10-31 |
2007-10-03 |
Danisco A/S |
Pyranosone dehydratase from phanerochaete chrysosporium
|
CA2467719C
(en)
|
2001-11-14 |
2015-03-17 |
Jill Giles-Komar |
Anti-il-6 antibodies, compositions, methods and uses
|
JP2005518442A
(ja)
*
|
2001-11-20 |
2005-06-23 |
デューク・ユニバーシティー |
界面バイオマテリアル
|
US6768476B2
(en)
*
|
2001-12-05 |
2004-07-27 |
Etenna Corporation |
Capacitively-loaded bent-wire monopole on an artificial magnetic conductor
|
US7179907B2
(en)
|
2001-12-18 |
2007-02-20 |
Bruce Eaton |
Antibiotic compounds
|
US20030157534A1
(en)
*
|
2001-12-26 |
2003-08-21 |
Manuel Engelhorn |
DNA immunization with libraries of minigenes encoding degenerate variants of major histocompatability class l restricted epitopes
|
NZ533933A
(en)
|
2002-01-02 |
2008-06-30 |
Genentech Inc |
Compositions and methods for the diagnosis and treatment of glioma tumor
|
US20030224392A1
(en)
*
|
2002-01-28 |
2003-12-04 |
Manuel Engelhorn |
Method for identification of mutant antigens with enhanced immunogenicity
|
US20030157495A1
(en)
*
|
2002-02-01 |
2003-08-21 |
Padgett Hal S. |
Nucleic acid molecules encoding CEL I endonuclease and methods of use thereof
|
US7078211B2
(en)
*
|
2002-02-01 |
2006-07-18 |
Large Scale Biology Corporation |
Nucleic acid molecules encoding endonucleases and methods of use thereof
|
US7662924B2
(en)
*
|
2002-02-22 |
2010-02-16 |
The Board Of Trustees Of The University Of Illinois |
Beta chain-associated regulator of apoptosis
|
WO2003072738A2
(en)
*
|
2002-02-22 |
2003-09-04 |
Board Of Trustees Of The University Of Illinois |
Beta chain-associated regulator of apoptosis
|
US20030166010A1
(en)
*
|
2002-02-25 |
2003-09-04 |
Affholter Joseph A. |
Custom ligand design for biomolecular filtration and purification for bioseperation
|
US20030224404A1
(en)
*
|
2002-02-25 |
2003-12-04 |
Manuel Vega |
High throughput directed evolution of nucleic acids by rational mutagenesis
|
US7657380B2
(en)
*
|
2003-12-04 |
2010-02-02 |
Xencor, Inc. |
Methods of generating variant antibodies with increased host string content
|
US20040132101A1
(en)
|
2002-09-27 |
2004-07-08 |
Xencor |
Optimized Fc variants and methods for their generation
|
CA2481507A1
(en)
|
2002-04-16 |
2003-10-30 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
US7226771B2
(en)
|
2002-04-19 |
2007-06-05 |
Diversa Corporation |
Phospholipases, nucleic acids encoding them and methods for making and using them
|
BR0309391A
(pt)
|
2002-04-19 |
2005-10-25 |
Diversa Corp |
Fosfolipases, ácidos nucléicos codificando-as e métodos para preparar e usá-las
|
ES2285118T5
(es)
*
|
2002-05-17 |
2012-09-21 |
Alligator Bioscience Ab |
Un método para el desarrollo molecular in vitro de una función proteica.
|
AU2003239966B9
(en)
*
|
2002-06-03 |
2010-08-26 |
Genentech, Inc. |
Synthetic antibody phage libraries
|
DE60319259T2
(de)
*
|
2002-06-14 |
2009-03-05 |
Dyax Corp., Cambridge |
Rekombination von nukleinsäurebibliotheksmitgliedern
|
EP1552002A4
(en)
*
|
2002-06-18 |
2006-02-08 |
Archemix Corp |
APTAMER TOXIN MOLECULES AND METHOD FOR THEIR USE
|
AU2003261264B2
(en)
*
|
2002-07-25 |
2008-12-11 |
Archemix Corp. |
Regulated aptamer therapeutics
|
BR0313281A
(pt)
|
2002-08-06 |
2007-07-24 |
Verdia Inc |
variantes de ap1 amina oxidase
|
US20040067532A1
(en)
*
|
2002-08-12 |
2004-04-08 |
Genetastix Corporation |
High throughput generation and affinity maturation of humanized antibody
|
ATE466085T1
(de)
*
|
2002-09-09 |
2010-05-15 |
Hanall Pharmaceutical Co Ltd |
Protease-resistente modifizierte interferon alpha polypeptide
|
US20050202438A1
(en)
*
|
2002-09-09 |
2005-09-15 |
Rene Gantier |
Rational directed protein evolution using two-dimensional rational mutagenesis scanning
|
US20060020396A1
(en)
*
|
2002-09-09 |
2006-01-26 |
Rene Gantier |
Rational directed protein evolution using two-dimensional rational mutagenesis scanning
|
US9303262B2
(en)
|
2002-09-17 |
2016-04-05 |
Archemix Llc |
Methods for identifying aptamer regulators
|
US20050064508A1
(en)
*
|
2003-09-22 |
2005-03-24 |
Semzyme |
Peptide mediated synthesis of metallic and magnetic materials
|
CN1705491B
(zh)
|
2002-09-27 |
2013-05-29 |
赞科股份有限公司 |
优化的Fc变体及其产生方法
|
JP3447009B1
(ja)
*
|
2002-10-29 |
2003-09-16 |
實 平垣 |
構築物用構成体およびその製造方法
|
US8853376B2
(en)
|
2002-11-21 |
2014-10-07 |
Archemix Llc |
Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
|
CA2504633A1
(en)
*
|
2002-11-21 |
2004-06-10 |
Archemix Corporation |
Multivalent aptamer therapeutics with improved pharmacodynamic properties and methods of making and using the same
|
US20050124565A1
(en)
*
|
2002-11-21 |
2005-06-09 |
Diener John L. |
Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
|
US10100316B2
(en)
|
2002-11-21 |
2018-10-16 |
Archemix Llc |
Aptamers comprising CPG motifs
|
WO2004050899A2
(en)
*
|
2002-12-03 |
2004-06-17 |
Archemix Corporation |
Method for in vitro selection of 2’-substituted nucleic acids
|
US20050037394A1
(en)
*
|
2002-12-03 |
2005-02-17 |
Keefe Anthony D. |
Method for in vitro selection of 2'-substituted nucleic acids
|
WO2004058818A2
(en)
*
|
2002-12-26 |
2004-07-15 |
Applied Research Systems Ars Holding N.V. |
Spliced variants of lgr6
|
EP1585767A2
(en)
*
|
2003-01-16 |
2005-10-19 |
Genentech, Inc. |
Synthetic antibody phage libraries
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
ES2713024T3
(es)
|
2003-03-06 |
2019-05-17 |
Basf Enzymes Llc |
Amilasas, ácidos nucleicos que las codifican y métodos para su fabricación y uso
|
US8298799B2
(en)
|
2003-03-07 |
2012-10-30 |
Dsm Ip Assets B. V. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
CA2521402C
(en)
|
2003-04-04 |
2015-01-13 |
Diversa Corporation |
Pectate lyases, nucleic acids encoding them and methods for making and using them
|
US20050250106A1
(en)
*
|
2003-04-24 |
2005-11-10 |
David Epstein |
Gene knock-down by intracellular expression of aptamers
|
US7964714B2
(en)
*
|
2003-05-12 |
2011-06-21 |
Potomac Pharmaceuticals Inc. |
Gene expression suppression agents
|
US9708410B2
(en)
|
2003-05-30 |
2017-07-18 |
Janssen Biotech, Inc. |
Anti-tissue factor antibodies and compositions
|
AU2004254640B2
(en)
|
2003-07-02 |
2010-08-26 |
Bp Corporation North America Inc. |
Glucanases, nucleic acids encoding them and methods for making and using them
|
WO2005012531A2
(en)
*
|
2003-08-01 |
2005-02-10 |
Genentech, Inc. |
Antibody cdr polypeptide sequences with restricted diversity
|
US20050054847A1
(en)
*
|
2003-08-01 |
2005-03-10 |
Invitrogen Corporation |
Compositions and methods for preparing short RNA molecules and other nucleic acids
|
US7741089B2
(en)
|
2003-08-11 |
2010-06-22 |
Verenium Corporation |
Laccases, nucleic acids encoding them and methods for making and using them
|
JP2005065575A
(ja)
*
|
2003-08-22 |
2005-03-17 |
Japan Science & Technology Agency |
フレームシャッフリングによるタンパク質分子多様性集団の作製
|
US20050042664A1
(en)
*
|
2003-08-22 |
2005-02-24 |
Medimmune, Inc. |
Humanization of antibodies
|
US20060134105A1
(en)
*
|
2004-10-21 |
2006-06-22 |
Xencor, Inc. |
IgG immunoglobulin variants with optimized effector function
|
US8883147B2
(en)
|
2004-10-21 |
2014-11-11 |
Xencor, Inc. |
Immunoglobulins insertions, deletions, and substitutions
|
US8399618B2
(en)
|
2004-10-21 |
2013-03-19 |
Xencor, Inc. |
Immunoglobulin insertions, deletions, and substitutions
|
PT2161283E
(pt)
|
2003-11-17 |
2014-08-29 |
Genentech Inc |
Composições que compreendem anticorpos contra cd79b conjugados a um agente de inibição do crescimento ou agente citotóxico e métodos para o tratamento de tumor de origem hematopoiética
|
US20050112585A1
(en)
*
|
2003-11-21 |
2005-05-26 |
Dominic Zichi |
Method for adjusting the quantification range of individual analytes in a multiplexed assay
|
EP1701672A4
(en)
*
|
2003-12-19 |
2011-04-27 |
Osteotech Inc |
TISSUE-BASED MESH FOR BONE REGENERATION
|
PT1727567E
(pt)
|
2004-02-12 |
2013-10-14 |
Archemix Llc |
Terapêuticas com aptâmeros úteis no tratamento de desordens relacionadas com o complemento
|
US7803931B2
(en)
|
2004-02-12 |
2010-09-28 |
Archemix Corp. |
Aptamer therapeutics useful in the treatment of complement-related disorders
|
US20070066550A1
(en)
*
|
2004-03-05 |
2007-03-22 |
Diener John L |
Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics
|
US20060193821A1
(en)
*
|
2004-03-05 |
2006-08-31 |
Diener John L |
Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics
|
US7569223B2
(en)
*
|
2004-03-22 |
2009-08-04 |
The Rockefeller University |
Phage-associated lytic enzymes for treatment of Streptococcus pneumoniae and related conditions
|
EP2053062A1
(en)
|
2004-03-24 |
2009-04-29 |
Xencor, Inc. |
Immunoglobin variants outside the Fc region
|
US7785903B2
(en)
*
|
2004-04-09 |
2010-08-31 |
Genentech, Inc. |
Variable domain library and uses
|
US20080214489A1
(en)
*
|
2004-04-19 |
2008-09-04 |
Anthony Dominic Keefe |
Aptamer-mediated intracellular delivery of oligonucleotides
|
PL1745062T3
(pl)
*
|
2004-04-22 |
2014-10-31 |
Regado Biosciences Inc |
Ulepszone modulatory czynników krzepnięcia
|
US7579450B2
(en)
|
2004-04-26 |
2009-08-25 |
Archemix Corp. |
Nucleic acid ligands specific to immunoglobulin E and their use as atopic disease therapeutics
|
EP2017620A3
(en)
|
2004-04-28 |
2009-04-22 |
Bayer HealthCare AG |
Diagnostics and therapeutics for diseases associated with dipeptidyl-peptidase 1 (DPP1)
|
US20060292554A1
(en)
*
|
2004-05-18 |
2006-12-28 |
Genentech, Inc. |
Major coat protein variants for C-terminal and bi-terminal display
|
AU2005264938B2
(en)
|
2004-06-16 |
2011-11-24 |
Verenium Corporation |
Compositions and methods for enzymatic decolorization of chlorophyll
|
JP2008512097A
(ja)
*
|
2004-09-07 |
2008-04-24 |
アーケミックス コーポレイション |
アプタマー医薬品化学
|
EP1789096A4
(en)
|
2004-09-07 |
2009-07-08 |
Archemix Corp |
APTAMERS FOR THE VON WILLEBRAND FACTOR AND ITS USE AS THERAPEUTICS FOR THROMBOTIC DISEASES
|
US7566701B2
(en)
*
|
2004-09-07 |
2009-07-28 |
Archemix Corp. |
Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics
|
GB0422052D0
(en)
|
2004-10-04 |
2004-11-03 |
Dansico As |
Enzymes
|
GB0423139D0
(en)
*
|
2004-10-18 |
2004-11-17 |
Danisco |
Enzymes
|
WO2006053301A2
(en)
|
2004-11-12 |
2006-05-18 |
Xencor, Inc. |
Fc variants with altered binding to fcrn
|
CA2594356C
(en)
|
2005-01-05 |
2018-07-17 |
F-Star Biotechnologische Forschungs- Und Entwicklungsges.M.B.H. |
Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions
|
PA8660701A1
(es)
|
2005-02-04 |
2006-09-22 |
Pfizer Prod Inc |
Agonistas de pyy y sus usos
|
AU2006212807A1
(en)
|
2005-02-08 |
2006-08-17 |
Zymogenetics, Inc. |
Anti-IL-20, anti-IL-22 and anti-IL-22RA antibodies and binding partners and methods of using in inflammation
|
CA2614769A1
(en)
|
2005-03-10 |
2006-09-21 |
Verenium Corporation |
Lyase enzymes, nucleic acids encoding them and methods for making and using them
|
AU2006223498A1
(en)
|
2005-03-10 |
2006-09-21 |
Genentech, Inc. |
Methods and compositions for modulating vascular integrity
|
EP1861506B1
(en)
|
2005-03-15 |
2015-04-15 |
BP Corporation North America Inc. |
Cellulases, nucleic acids encoding them and methods for making and using them
|
PA8672101A1
(es)
|
2005-04-29 |
2006-12-07 |
Centocor Inc |
Anticuerpos anti-il-6, composiciones, métodos y usos
|
WO2006124667A2
(en)
|
2005-05-12 |
2006-11-23 |
Zymogenetics, Inc. |
Compositions and methods for modulating immune responses
|
US20060271262A1
(en)
*
|
2005-05-24 |
2006-11-30 |
Mclain Harry P Iii |
Wireless agricultural network
|
US8389469B2
(en)
*
|
2005-06-06 |
2013-03-05 |
The Rockefeller University |
Bacteriophage lysins for Bacillus anthracis
|
US7582291B2
(en)
*
|
2005-06-30 |
2009-09-01 |
The Rockefeller University |
Bacteriophage lysins for Enterococcus faecalis, Enterococcus faecium and other bacteria
|
NZ596992A
(en)
*
|
2005-06-30 |
2013-07-26 |
Abbott Lab |
Il-12/p40 binding proteins
|
EP1896073B1
(en)
|
2005-06-30 |
2013-03-06 |
Janssen Biotech, Inc. |
Anti-il-23 antibodies, compositions, methods and uses
|
EP2500358A3
(en)
|
2005-08-19 |
2012-10-17 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
WO2007024715A2
(en)
|
2005-08-19 |
2007-03-01 |
Abbott Laboratories |
Dual variable domain immunoglobin and uses thereof
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
US20090215992A1
(en)
*
|
2005-08-19 |
2009-08-27 |
Chengbin Wu |
Dual variable domain immunoglobulin and uses thereof
|
CN101297034A
(zh)
|
2005-08-24 |
2008-10-29 |
洛克菲勒大学 |
Ply-gbs突变溶素
|
WO2007035527A2
(en)
|
2005-09-15 |
2007-03-29 |
Duke University |
Non-fouling polymeric surface modification and signal amplification method for biomolecular detection
|
CN101277974A
(zh)
*
|
2005-09-30 |
2008-10-01 |
阿伯特有限及两合公司 |
排斥性引导分子(rgm)蛋白质家族的蛋白质的结合结构域及其功能性片段和它们的用途
|
ES2577292T3
(es)
|
2005-11-07 |
2016-07-14 |
Genentech, Inc. |
Polipéptidos de unión con secuencias hipervariables de VH/VL diversificadas y consenso
|
GB2432366B
(en)
*
|
2005-11-19 |
2007-11-21 |
Alligator Bioscience Ab |
A method for in vitro molecular evolution of protein function
|
PT1976877E
(pt)
*
|
2005-11-30 |
2014-04-29 |
Abbvie Inc |
Anticorpos monoclonais contra proteína beta-amilóide e suas utilizações
|
EP1954718B1
(en)
*
|
2005-11-30 |
2014-09-03 |
AbbVie Inc. |
Anti-a globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies
|
EP1973951A2
(en)
*
|
2005-12-02 |
2008-10-01 |
Genentech, Inc. |
Binding polypeptides with restricted diversity sequences
|
HUE049832T2
(hu)
|
2005-12-29 |
2020-10-28 |
Janssen Biotech Inc |
Humán anti-IL-23 ellenanyagok, készítmények, eljárás és alkalmazások
|
EP1987142A4
(en)
|
2006-02-02 |
2009-07-15 |
Verenium Corp |
ESTERASES AND ASSOCIATED NUCLEIC ACIDS AND METHODS
|
WO2007092313A2
(en)
*
|
2006-02-03 |
2007-08-16 |
Indiana University Research And Technology Corporation |
Construction of open reading frame libraries and protein structures
|
NZ595499A
(en)
|
2006-02-10 |
2013-05-31 |
Verenium Corp |
Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them
|
US8043839B2
(en)
|
2006-02-14 |
2011-10-25 |
Verenium Corporation |
Xylanases, nucleic acids encoding them and methods for making and using them
|
CN101437954B
(zh)
|
2006-03-07 |
2015-09-09 |
嘉吉公司 |
醛缩酶和编码醛缩酶的核酸以及它们的制备和使用方法
|
EA029538B1
(ru)
|
2006-03-07 |
2018-04-30 |
Басф Энзаймс Ллк |
Полипептид, обладающий активностью альдолазы, полинуклеотид, кодирующий этот полипептид, и способы получения и применения полинуклеотида и полипептида
|
WO2007103549A2
(en)
*
|
2006-03-08 |
2007-09-13 |
Archemix Corp. |
Complement binding aptamers and anti-c5 agents useful in the treatment of ocular disorders
|
CA2647277A1
(en)
|
2006-04-05 |
2007-11-08 |
Genentech, Inc. |
Method for using boc/cdo to modulate hedgehog signaling
|
WO2007134050A2
(en)
*
|
2006-05-09 |
2007-11-22 |
Genentech, Inc. |
Binding polypeptides with optimized scaffolds
|
AT503902B1
(de)
*
|
2006-07-05 |
2008-06-15 |
F Star Biotech Forsch & Entw |
Verfahren zur manipulation von immunglobulinen
|
AT503861B1
(de)
|
2006-07-05 |
2008-06-15 |
F Star Biotech Forsch & Entw |
Verfahren zur manipulation von t-zell-rezeptoren
|
AT503889B1
(de)
*
|
2006-07-05 |
2011-12-15 |
Star Biotechnologische Forschungs Und Entwicklungsges M B H F |
Multivalente immunglobuline
|
EP2046826B1
(en)
|
2006-07-24 |
2011-09-14 |
Biorexis Pharmaceutical Corporation |
Exendin fusion proteins
|
BRPI0714876B1
(pt)
|
2006-08-04 |
2022-04-19 |
Verenium Corporation |
Ácido nucleico isolado, sintético ou recombinante, cassete de expressão, vetor ou veículo de clonagem, célula bacteriana, fúngica ou de levedura transformada, polipeptídeo isolado, sintético ou recombinante, composição, bem como métodos de produção e de usos dos mesmos
|
CA2660286A1
(en)
|
2006-08-09 |
2008-02-21 |
Homestead Clinical Corporation |
Organ-specific proteins and methods of their use
|
CA2914170C
(en)
|
2006-09-08 |
2018-10-30 |
Abbvie Bahamas Ltd. |
Interleukin-13 binding proteins
|
US20100297103A1
(en)
|
2006-09-14 |
2010-11-25 |
Medical & Biological Laboratories Co., Ltd. |
Antibody having enhanced adcc activity and method for production thereof
|
WO2008036863A2
(en)
|
2006-09-21 |
2008-03-27 |
Verenium Corporation |
Phospholipases, nucleic acids encoding them and methods for making and using them
|
EP2617814B1
(en)
|
2006-09-21 |
2015-11-18 |
BASF Enzymes LLC |
Phytases, nucleic acids encoding them and methods for making and using them
|
US9382327B2
(en)
|
2006-10-10 |
2016-07-05 |
Vaccinex, Inc. |
Anti-CD20 antibodies and methods of use
|
US8455626B2
(en)
|
2006-11-30 |
2013-06-04 |
Abbott Laboratories |
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
|
EP2479266B1
(en)
|
2006-12-21 |
2016-03-09 |
BASF Enzymes LLC |
Amylases and glucoamylases, nucleic acids encoding them and methods for making and using them
|
US7855054B2
(en)
|
2007-01-16 |
2010-12-21 |
Somalogic, Inc. |
Multiplexed analyses of test samples
|
US7964356B2
(en)
|
2007-01-16 |
2011-06-21 |
Somalogic, Inc. |
Method for generating aptamers with improved off-rates
|
US7947447B2
(en)
|
2007-01-16 |
2011-05-24 |
Somalogic, Inc. |
Method for generating aptamers with improved off-rates
|
US8975026B2
(en)
|
2007-01-16 |
2015-03-10 |
Somalogic, Inc. |
Method for generating aptamers with improved off-rates
|
US20110136099A1
(en)
|
2007-01-16 |
2011-06-09 |
Somalogic, Inc. |
Multiplexed Analyses of Test Samples
|
AU2008205457A1
(en)
*
|
2007-01-18 |
2008-07-24 |
University Of Southern California |
Gene polymorphisms predictive for dual TKI therapy
|
NZ598285A
(en)
|
2007-01-30 |
2013-10-25 |
Syngenta Participations Ag |
Enzymes for the treatment of lignocellulosics, nucleic acids encoding them and methods for making and using them
|
US8143046B2
(en)
|
2007-02-07 |
2012-03-27 |
Danisco Us Inc., Genencor Division |
Variant Buttiauxella sp. phytases having altered properties
|
CA2678451A1
(en)
*
|
2007-02-20 |
2008-08-28 |
Robert A. Horlick |
Somatic hypermutation systems
|
WO2008103962A2
(en)
|
2007-02-22 |
2008-08-28 |
Genentech, Inc. |
Methods for detecting inflammatory bowel disease
|
US20100311767A1
(en)
*
|
2007-02-27 |
2010-12-09 |
Abbott Gmbh & Co. Kg |
Method for the treatment of amyloidoses
|
PE20090329A1
(es)
*
|
2007-05-30 |
2009-03-27 |
Abbott Lab |
Anticuerpos humanizados contra el globulomero ab(20-42) y sus usos
|
US20090232801A1
(en)
*
|
2007-05-30 |
2009-09-17 |
Abbot Laboratories |
Humanized Antibodies Which Bind To AB (1-42) Globulomer And Uses Thereof
|
WO2008150495A2
(en)
*
|
2007-06-01 |
2008-12-11 |
Archemix Corp. |
Vwf aptamer formulations and methods for use
|
US8921279B2
(en)
|
2007-06-26 |
2014-12-30 |
F-Star Biotechnologische Forschungs—und Entwicklungsges. m.b.H |
Display of binding agents
|
EP2489743B1
(en)
|
2007-07-17 |
2015-01-07 |
Somalogic, Inc. |
Aptamers with 5-(N-naphthyl)-substituted uridines
|
EP2033971A1
(de)
*
|
2007-09-06 |
2009-03-11 |
Abbott GmbH & Co. KG |
Bone Morphogenetic Protein (BMP)-bindende Domänen von Proteinen der Repulsive Guidance Molecule (RGM) Proteinfamilie und funktionale Fragmente davon sowie deren Verwendung
|
US8877688B2
(en)
|
2007-09-14 |
2014-11-04 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
EP3753947A1
(en)
|
2007-09-14 |
2020-12-23 |
Adimab, LLC |
Rationally designed, synthetic antibody libraries and uses therefor
|
NZ583944A
(en)
|
2007-09-28 |
2012-06-29 |
Portola Pharm Inc |
Antidotes for factor xa inhibitors and methods of using the same
|
EP2205744B1
(en)
|
2007-10-03 |
2015-01-14 |
BP Corporation North America Inc. |
Xylanases, nucleic acids encoding them and methods for making and using them
|
EP2215108A4
(en)
|
2007-10-23 |
2012-07-04 |
Univ Colorado |
COMPETITIVE INHIBITORS OF THE EXPRESSION OF THE CONSTANT CHAIN AND / OR THE ECTOPIC CLIP BINDING
|
US8663980B2
(en)
*
|
2007-10-26 |
2014-03-04 |
Janssen Biotech, Inc. |
Vectors, host cells, and methods of production and uses
|
US8906700B2
(en)
|
2007-11-06 |
2014-12-09 |
Ambergen, Inc. |
Methods and compositions for phototransfer
|
DK2242843T3
(en)
*
|
2007-12-31 |
2015-07-20 |
Xoma Technology Ltd |
Methods and materials for targeted mutagenesis
|
CA2710922A1
(en)
|
2008-01-03 |
2009-07-16 |
Verenium Corporation |
Isomerases, nucleic acids encoding them and methods for making and using them
|
JP5563990B2
(ja)
|
2008-01-03 |
2014-07-30 |
ヴェレニウム コーポレイション |
トランスフェラーゼおよびオキシドレダクターゼ、それらをコードする核酸並びにそれらを製造および使用する方法
|
US7682809B2
(en)
|
2008-01-11 |
2010-03-23 |
Agilent Technologies, Inc. |
Direct ATP release sequencing
|
US8962803B2
(en)
*
|
2008-02-29 |
2015-02-24 |
AbbVie Deutschland GmbH & Co. KG |
Antibodies against the RGM A protein and uses thereof
|
US9873957B2
(en)
*
|
2008-03-13 |
2018-01-23 |
Dyax Corp. |
Libraries of genetic packages comprising novel HC CDR3 designs
|
AU2009240481B2
(en)
*
|
2008-04-24 |
2015-07-30 |
Takeda Pharmaceutical Company Limited |
Libraries of genetic packages comprising novel HC CDR1, CDR2, and CDR3 and novel LC CDR1, CDR2, and CDR3 designs
|
US20100260668A1
(en)
*
|
2008-04-29 |
2010-10-14 |
Abbott Laboratories |
Dual Variable Domain Immunoglobulins and Uses Thereof
|
NZ588554A
(en)
|
2008-04-29 |
2013-03-28 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
CN102083996A
(zh)
|
2008-04-30 |
2011-06-01 |
丹尼斯科公司 |
氧化方法
|
EP2113255A1
(en)
|
2008-05-02 |
2009-11-04 |
f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. |
Cytotoxic immunoglobulin
|
SG188142A1
(en)
|
2008-05-09 |
2013-03-28 |
Abbott Gmbh & Co Kg |
Antibodies to receptor of advanced glycation end products (rage) and uses thereof
|
CN102112494A
(zh)
|
2008-06-03 |
2011-06-29 |
雅培制药有限公司 |
双重可变结构域免疫球蛋白及其用途
|
AR072001A1
(es)
|
2008-06-03 |
2010-07-28 |
Abbott Lab |
Inmunoglobulina con dominio variable dual y usos de la misma
|
EP2319869B1
(en)
*
|
2008-06-20 |
2016-08-17 |
National University Corporation Okayama University |
ANTIBODY AGAINST OXIDIZED LDL/ß²GPI COMPLEX AND USE OF THE SAME
|
EP2303318A2
(en)
|
2008-06-20 |
2011-04-06 |
Wyeth LLC |
Compositions and methods of use of orf1358 from beta-hemolytic streptococcal strains
|
WO2010006060A2
(en)
*
|
2008-07-08 |
2010-01-14 |
Abbott Laboratories |
Prostaglandin e2 dual variable domain immunoglobulins and uses thereof
|
TW201014602A
(en)
|
2008-07-08 |
2010-04-16 |
Abbott Lab |
Prostaglandin E2 binding proteins and uses thereof
|
US8703416B2
(en)
|
2008-07-17 |
2014-04-22 |
Somalogic, Inc. |
Method for purification and identification of sperm cells
|
US20100166782A1
(en)
*
|
2008-07-25 |
2010-07-01 |
Martha Karen Newell |
Clip inhibitors and methods of modulating immune function
|
CA2736842A1
(en)
*
|
2008-07-25 |
2010-01-28 |
The Regents Of The University Of Colorado |
Proteins for use in diagnosing and treating infection and disease
|
US9182406B2
(en)
|
2008-08-04 |
2015-11-10 |
Biodesy, Inc. |
Nonlinear optical detection of molecules comprising an unnatural amino acid possessing a hyperpolarizability
|
CA2733642A1
(en)
|
2008-08-14 |
2010-02-18 |
Cephalon Australia Pty Ltd |
Anti-il-12/il-23 antibodies
|
US8198062B2
(en)
|
2008-08-29 |
2012-06-12 |
Dsm Ip Assets B.V. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
US8153391B2
(en)
|
2008-08-29 |
2012-04-10 |
Bunge Oils, Inc. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
US8357503B2
(en)
|
2008-08-29 |
2013-01-22 |
Bunge Oils, Inc. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
JP5390621B2
(ja)
|
2008-10-20 |
2014-01-15 |
グワンジュ・インスティテュート・オブ・サイエンス・アンド・テクノロジー |
二座ペプチドバインダー
|
RU2011127198A
(ru)
*
|
2008-12-04 |
2013-01-10 |
Эбботт Лэборетриз |
Иммуноглобулины с двойными вариабельными доменами и их применение
|
WO2010084488A1
(en)
|
2009-01-20 |
2010-07-29 |
Ramot At Tel-Aviv University Ltd. |
Mir-21 promoter driven targeted cancer therapy
|
US20110165063A1
(en)
*
|
2009-01-29 |
2011-07-07 |
Abbott Laboratories |
Il-1 binding proteins
|
CA2749966A1
(en)
*
|
2009-01-29 |
2010-08-05 |
Abbott Laboratories |
Il-1 binding proteins
|
US8030026B2
(en)
|
2009-02-24 |
2011-10-04 |
Abbott Laboratories |
Antibodies to troponin I and methods of use thereof
|
JP5836807B2
(ja)
|
2009-03-05 |
2015-12-24 |
アッヴィ・インコーポレイテッド |
Il−17結合タンパク質
|
EP3604510A1
(en)
|
2009-03-30 |
2020-02-05 |
Portola Pharmaceuticals, Inc. |
Antidotes for factor xa inhibitors and methods of using the same
|
GB0908770D0
(en)
|
2009-04-24 |
2009-07-01 |
Danisco |
Method
|
US9695403B2
(en)
|
2009-05-21 |
2017-07-04 |
Syngenta Participations Ag |
Phytases, nucleic acids encoding them and methods for making and using them
|
ES2605801T3
(es)
|
2009-07-15 |
2017-03-16 |
Portola Pharmaceuticals, Inc. |
Formulación de dosis unitaria de antídoto para inhibidores del factor Xa para su uso en la prevención de la hemorragia
|
UY32808A
(es)
*
|
2009-07-29 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas como dominio variable dual y usos de las mismas
|
CN105131112A
(zh)
|
2009-08-29 |
2015-12-09 |
Abbvie公司 |
治疗用dll4结合蛋白
|
EP2473524A4
(en)
|
2009-09-01 |
2013-05-22 |
Abbott Lab |
IMMUNOGLOBULINE WITH DOUBLE VARIABLE DOMAIN AND ITS USE
|
US20110082054A1
(en)
*
|
2009-09-14 |
2011-04-07 |
Dyax Corp. |
Libraries of genetic packages comprising novel hc cdr3 designs
|
WO2011038301A2
(en)
|
2009-09-25 |
2011-03-31 |
Xoma Technology Ltd. |
Screening methods
|
US8926976B2
(en)
*
|
2009-09-25 |
2015-01-06 |
Xoma Technology Ltd. |
Modulators
|
EP2488658A4
(en)
|
2009-10-15 |
2013-06-19 |
Abbvie Inc |
IMMUNOGLOBULINE WITH DOUBLE VARIABLE DOMAIN AND ITS USE
|
UA109884C2
(uk)
|
2009-10-16 |
2015-10-26 |
|
Поліпептид, що має активність ферменту фосфатидилінозитол-специфічної фосфоліпази с, нуклеїнова кислота, що його кодує, та спосіб його виробництва і застосування
|
UA111708C2
(uk)
|
2009-10-16 |
2016-06-10 |
Бандж Ойлз, Інк. |
Спосіб рафінування олії
|
KR20120105446A
(ko)
|
2009-10-22 |
2012-09-25 |
제넨테크, 인크. |
대식세포-자극 단백질의 헵신 활성화를 조정하기 위한 방법 및 조성물
|
UY32979A
(es)
*
|
2009-10-28 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
WO2011053707A1
(en)
|
2009-10-31 |
2011-05-05 |
Abbott Laboratories |
Antibodies to receptor for advanced glycation end products (rage) and uses thereof
|
AU2010324686B2
(en)
|
2009-11-30 |
2016-05-19 |
Genentech, Inc. |
Antibodies for treating and diagnosing tumors expressing SLC34A2 (TAT211 = SEQID2 )
|
MX2012006560A
(es)
|
2009-12-08 |
2012-10-05 |
Abbott Gmbh & Co Kg |
Anticuerpos monoclonales contra la proteina rgm a para utilizarse en el tratamiento de degeneracion de capa de fibra de nervio retinal.
|
RU2573994C2
(ru)
|
2010-02-10 |
2016-01-27 |
Иммьюноджен, Инк |
Антитела против cd20 и их применение
|
US9556249B2
(en)
|
2010-02-18 |
2017-01-31 |
Genentech, Inc. |
Neuregulin antagonists and use thereof in treating cancer
|
US8877897B2
(en)
|
2010-02-23 |
2014-11-04 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
NZ724971A
(en)
|
2010-02-24 |
2019-06-28 |
Immunogen Inc |
Folate receptor 1 antibodies and immunoconjugates and uses thereof
|
MY160628A
(en)
|
2010-03-02 |
2017-03-15 |
Abbvie Inc |
Therapeutic DLL4 Binding Proteins
|
WO2011109642A1
(en)
|
2010-03-03 |
2011-09-09 |
Somalogic, Inc. |
Aptamers to 4-1bb and their use in treating diseases and disorders
|
PE20130192A1
(es)
|
2010-03-30 |
2013-02-27 |
Centocor Ortho Biotech Inc |
Anticuerpos il-25 humanizados
|
CN104069512A
(zh)
|
2010-04-12 |
2014-10-01 |
私募蛋白质体公司 |
针对β-NGF的适体及其在治疗β-NGF介导的疾病和失调中的用途
|
JP2013523182A
(ja)
|
2010-04-15 |
2013-06-17 |
アボット・ラボラトリーズ |
アミロイドベータ結合タンパク質
|
BR112012028010A2
(pt)
|
2010-05-03 |
2017-09-26 |
Genentech Inc |
anticorpo isolado, célula, ácido nucleíco isolado, método de identificação de um primeiro anticorpo que se liga a um epítopo antigênico tat425 ligado or um anticorpo, métodos de inibir o crescimento de uma célula, de tratamento terapêutico de determinação da presença de uma proteína de tat425 e de diagnóstico da presença de um tumor em um mamífero
|
PE20130205A1
(es)
|
2010-05-14 |
2013-03-24 |
Abbvie Inc |
Proteinas de union a il-1
|
WO2012006500A2
(en)
|
2010-07-08 |
2012-01-12 |
Abbott Laboratories |
Monoclonal antibodies against hepatitis c virus core protein
|
GB201011513D0
(en)
|
2010-07-08 |
2010-08-25 |
Danisco |
Method
|
UY33492A
(es)
|
2010-07-09 |
2012-01-31 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
US9354228B2
(en)
|
2010-07-16 |
2016-05-31 |
Adimab, Llc |
Antibody libraries
|
EP3252072A3
(en)
|
2010-08-03 |
2018-03-14 |
AbbVie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
EP2603524A1
(en)
|
2010-08-14 |
2013-06-19 |
AbbVie Inc. |
Amyloid-beta binding proteins
|
EP2606067B1
(en)
|
2010-08-19 |
2018-02-21 |
Zoetis Belgium S.A. |
Anti-ngf antibodies and their use
|
KR20130139884A
(ko)
|
2010-08-26 |
2013-12-23 |
애브비 인코포레이티드 |
이원 가변 도메인 면역글로불린 및 이의 용도
|
AR083354A1
(es)
|
2010-10-06 |
2013-02-21 |
Bp Corp North America Inc |
Polipeptidos variantes cbh i (celobiohidrolasas i) con reducida inhibicion de producto
|
SG191312A1
(en)
|
2010-12-21 |
2013-07-31 |
Abbvie Inc |
Il-1 -alpha and -beta bispecific dual variable domain immunoglobulins and their use
|
US20120275996A1
(en)
|
2010-12-21 |
2012-11-01 |
Abbott Laboratories |
IL-1 Binding Proteins
|
US9683054B2
(en)
|
2010-12-31 |
2017-06-20 |
BioAlta, LLC |
Express humanization of antibodies
|
US9428789B2
(en)
|
2011-03-21 |
2016-08-30 |
Biodesy, Inc. |
Classification of kinase inhibitors using nonlinear optical techniques
|
EP3252155A1
(en)
|
2011-04-21 |
2017-12-06 |
The Rockefeller University |
Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria
|
WO2013009521A2
(en)
|
2011-07-13 |
2013-01-17 |
Abbvie Inc. |
Methods and compositions for treating asthma using anti-il-13 antibodies
|
US8609355B2
(en)
|
2011-07-26 |
2013-12-17 |
Indicator Systems International, Inc. |
Assays for the detection of microbes
|
MX2014003094A
(es)
|
2011-09-15 |
2014-04-25 |
Genentech Inc |
Metodos para promover diferenciacion.
|
US9279118B2
(en)
|
2011-10-05 |
2016-03-08 |
The Rockefeller University |
Dimeric bacteriophage lysins
|
RU2014119426A
(ru)
|
2011-10-15 |
2015-11-20 |
Дженентек, Инк. |
Способы применения антагонистов scd1
|
UY34411A
(es)
|
2011-10-24 |
2013-05-31 |
Abbvie Inc |
Inmunoenlazantes dirigidos contra esclerostina
|
DK2797957T3
(da)
|
2011-11-23 |
2019-09-23 |
Medimmune Llc |
Bindingsmolekyler specifikke for her3 og anvendelser deraf
|
CA2855570A1
(en)
|
2011-12-14 |
2013-06-20 |
AbbVie Deutschland GmbH & Co. KG |
Composition and method for the diagnosis and treatment of iron-related disorders
|
AU2012352168C1
(en)
|
2011-12-14 |
2018-01-25 |
AbbVie Deutschland GmbH & Co. KG |
Composition and method for the diagnosis and treatment of iron-related disorders
|
CN104159920A
(zh)
|
2011-12-30 |
2014-11-19 |
艾伯维公司 |
针对il-13和/或il-17的双重可变结构域免疫球蛋白
|
CA2862424A1
(en)
|
2012-01-18 |
2013-07-25 |
Genentech, Inc. |
Methods of using fgf19 modulators
|
BR112014017814A8
(pt)
|
2012-01-20 |
2017-07-11 |
Genzyme Corp |
Anticorpos anti-cxcr3
|
RS57603B1
(sr)
|
2012-01-27 |
2018-11-30 |
Abbvie Deutschland |
Sastav i metod za dijagnozu i tretiranje bolesti povezanih sa degeneracijom neurita
|
RU2014133069A
(ru)
|
2012-02-11 |
2016-04-10 |
Дженентек, Инк. |
Транслокации r-спондина и способы с их использованием
|
US20140170159A9
(en)
|
2012-03-08 |
2014-06-19 |
Ge Wei |
Conditionally active anti-epidermal growth factor receptor antibodies and methods of use thereof
|
KR102143887B1
(ko)
|
2012-03-16 |
2020-08-12 |
유니버시티 헬스 네트워크 |
Toso 활성을 조절하기 위한 방법 및 조성물
|
CA2866835A1
(en)
|
2012-03-16 |
2013-09-19 |
Genentech, Inc. |
Engineered conformationally-stabilized proteins
|
US9139863B2
(en)
|
2012-03-16 |
2015-09-22 |
Genentech, Inc. |
Engineered conformationally-stabilized proteins
|
MX2014010953A
(es)
|
2012-03-16 |
2014-10-13 |
Hoffmann La Roche |
Metodos para tratamiento de melanoma con inhibidores pak1.
|
US9592289B2
(en)
|
2012-03-26 |
2017-03-14 |
Sanofi |
Stable IgG4 based binding agent formulations
|
EP2841951B1
(en)
|
2012-04-25 |
2019-12-11 |
Biodesy, Inc. |
Methods for detecting allosteric modulators of proteins
|
WO2013170191A1
(en)
|
2012-05-11 |
2013-11-14 |
Genentech, Inc. |
Methods of using antagonists of nad biosynthesis from nicotinamide
|
IN2014KN02831A
(xx)
|
2012-05-24 |
2015-05-08 |
Mountgate Group Ltd |
|
WO2013184871A1
(en)
|
2012-06-06 |
2013-12-12 |
Zoetis Llc |
Caninized anti-ngf antibodies and methods thereof
|
WO2014011955A2
(en)
|
2012-07-12 |
2014-01-16 |
Abbvie, Inc. |
Il-1 binding proteins
|
KR20240005129A
(ko)
|
2012-08-31 |
2024-01-11 |
이뮤노젠 아이엔씨 |
엽산 수용체 1의 검출을 위한 진단성 검정 및 키트
|
KR20180008921A
(ko)
|
2012-11-01 |
2018-01-24 |
애브비 인코포레이티드 |
항-vegf/dll4 이원 가변 도메인 면역글로불린 및 이의 용도
|
WO2014100542A1
(en)
|
2012-12-21 |
2014-06-26 |
Abbvie, Inc. |
High-throughput antibody humanization
|
CN104994879A
(zh)
|
2013-02-22 |
2015-10-21 |
霍夫曼-拉罗奇有限公司 |
治疗癌症和预防药物抗性的方法
|
JP2016510751A
(ja)
|
2013-03-06 |
2016-04-11 |
ジェネンテック, インコーポレイテッド |
抗がん剤耐性を治療及び予防する方法
|
GB201308828D0
(en)
|
2013-03-12 |
2013-07-03 |
Verenium Corp |
Phytase
|
BR112015023355A8
(pt)
|
2013-03-14 |
2018-01-30 |
Abbott Lab |
antígenos recombinantes ns3 de hcv e mutantes dos mesmos para detecção de anticorpos aprimorada.
|
MX2015012825A
(es)
|
2013-03-14 |
2016-06-10 |
Abbott Lab |
Anticuerpos monoclonales del dominio de union de lipido del núcleo del virus de la hepatitis c vhc.
|
GB201308843D0
(en)
|
2013-03-14 |
2013-07-03 |
Verenium Corp |
Phytase formulation
|
CA2906421C
(en)
|
2013-03-14 |
2022-08-16 |
George J. Dawson |
Hcv antigen-antibody combination assay and methods and compositions for use therein
|
BR112015022604A2
(pt)
|
2013-03-14 |
2017-10-24 |
Genentech Inc |
usos de um modulador de modificador de cromatina e um antagonista de egfr
|
RU2015143825A
(ru)
|
2013-03-15 |
2017-04-26 |
Пайонир Хай-Бред Интернэшнл, Инк. |
Полипептиды phi-4 и способы их применения
|
EP2968537A1
(en)
|
2013-03-15 |
2016-01-20 |
Genentech, Inc. |
Methods of treating cancer and preventing cancer drug resistance
|
CN105324396A
(zh)
|
2013-03-15 |
2016-02-10 |
艾伯维公司 |
针对IL-1β和/或IL-17的双重特异性结合蛋白
|
US9469686B2
(en)
|
2013-03-15 |
2016-10-18 |
Abbott Laboratories |
Anti-GP73 monoclonal antibodies and methods of obtaining the same
|
KR102158924B1
(ko)
|
2013-03-15 |
2020-09-22 |
제넨테크, 인크. |
Pd-1 및 pd-l1 관련 상태를 치료하기 위한 바이오마커 및 방법
|
EP3632467B1
(en)
|
2013-06-07 |
2023-09-27 |
Duke University |
Inhibitors of complement factor h
|
CN105408492A
(zh)
|
2013-07-25 |
2016-03-16 |
巴斯夫酶有限责任公司 |
肌醇六磷酸酶
|
EA030896B1
(ru)
|
2013-08-16 |
2018-10-31 |
Пайонир Хай-Бред Интернэшнл, Инк. |
Инсектицидные белки и способы их применения
|
IL293871A
(en)
|
2013-08-30 |
2022-08-01 |
Immunogen Inc |
Antibodies and assays for the detection of folate receptor 1
|
MX2016003256A
(es)
|
2013-09-12 |
2016-06-07 |
Halozyme Inc |
Anticuerpos modificados del receptor de factor de crecimiento anti-epidermico y metodos de uso de los mismos.
|
BR112016005543B1
(pt)
|
2013-09-13 |
2022-03-08 |
Pioneer Hi-Bred International, Inc |
Polipeptídeo pip-72 recombinante, construto de dna, método de obtenção de planta transgênica, célula hospedeira, composição, proteína de fusão, método para controlar uma população de praga de inseto, método para inibir o crescimento ou matar uma praga de inseto, método para controlar uma infestação de insetos em uma planta transgênica, método para identificar em uma amostra biológica uma sequência de nucleotídeos, método para identificar em uma amostra um polipeptídeo pip-72
|
CN106661107B
(zh)
|
2013-12-24 |
2021-12-24 |
杨森制药公司 |
抗vista抗体及片段
|
WO2015116902A1
(en)
|
2014-01-31 |
2015-08-06 |
Genentech, Inc. |
G-protein coupled receptors in hedgehog signaling
|
BR112016018103B1
(pt)
|
2014-02-07 |
2024-01-16 |
E.I. Du Pont De Nemours And Company |
Polipeptídeo e seu uso, polinucleotídeo, composição, proteína de fusão, método para controlar uma população, método para inibir o crescimento, método para controlar a infestação, método para obtenção de uma planta ou célula vegetal, construto
|
BR112016018287A2
(pt)
|
2014-02-07 |
2017-10-10 |
Du Pont |
proteínas inseticidas e métodos para uso das mesmas
|
KR20160127817A
(ko)
|
2014-03-07 |
2016-11-04 |
유니버시티 헬스 네트워크 |
면역 반응을 변형시키기 위한 방법 및 조성물
|
LT3128997T
(lt)
|
2014-04-08 |
2020-10-12 |
Boston Pharmaceuticals Inc. |
Surišančios molekulės, specifinės il-21, ir jų panaudojimas
|
US10160812B2
(en)
|
2014-04-11 |
2018-12-25 |
Medimmune, Llc |
Bispecific HER2 antibodies
|
GB201406767D0
(en)
|
2014-04-15 |
2014-05-28 |
Cancer Rec Tech Ltd |
Humanized anti-Tn-MUC1 antibodies anf their conjugates
|
JP6598798B2
(ja)
|
2014-05-05 |
2019-10-30 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
ヒト化c5およびc3動物
|
KR20170005016A
(ko)
|
2014-05-23 |
2017-01-11 |
제넨테크, 인크. |
MiT 바이오마커 및 그의 사용 방법
|
EP3154589A1
(en)
|
2014-06-13 |
2017-04-19 |
Genentech, Inc. |
Methods of treating and preventing cancer drug resistance
|
JP6655074B2
(ja)
|
2014-06-20 |
2020-02-26 |
ジェネンテック, インコーポレイテッド |
シャガシンに基づく足場組成物、方法及び使用
|
CA2963558C
(en)
|
2014-10-16 |
2023-04-04 |
Pioneer Hi-Bred International, Inc. |
Insecticidal proteins and methods for their use
|
EP3172329A1
(en)
|
2014-10-24 |
2017-05-31 |
Danisco US Inc. |
Method for producing alcohol by use of a tripeptidyl peptidase
|
DK3209773T3
(da)
|
2014-10-24 |
2020-06-15 |
Dupont Nutrition Biosci Aps |
Prolintolerante tripeptidylpeptidaser og anvendelser deraf
|
MY191423A
(en)
|
2014-11-10 |
2022-06-27 |
Medimmune Ltd |
Binding molecules specific for cd73 and uses thereof
|
WO2016075176A1
(en)
|
2014-11-11 |
2016-05-19 |
Medimmune Limited |
Therapeutic combinations comprising anti-cd73 antibodies and a2a receptor inhibitor and uses thereof
|
US10093733B2
(en)
|
2014-12-11 |
2018-10-09 |
Abbvie Inc. |
LRP-8 binding dual variable domain immunoglobulin proteins
|
WO2016106286A1
(en)
|
2014-12-23 |
2016-06-30 |
Biodesy, Inc. |
Attachment of proteins to interfaces for use in nonlinear optical detection
|
CN107530423B
(zh)
|
2015-01-14 |
2022-04-05 |
布里格姆及妇女医院股份有限公司 |
用抗lap单克隆抗体治疗癌症
|
WO2016144688A1
(en)
|
2015-03-11 |
2016-09-15 |
Pioneer Hi Bred International Inc |
Insecticidal combinations of pip-72 and methods of use
|
AU2016252773B2
(en)
|
2015-04-24 |
2022-06-02 |
Genentech, Inc. |
Multispecific antigen-binding proteins
|
CN108064233B
(zh)
|
2015-05-19 |
2022-07-15 |
先锋国际良种公司 |
杀昆虫蛋白及其使用方法
|
JP6518917B2
(ja)
|
2015-05-29 |
2019-05-29 |
アッヴィ・インコーポレイテッド |
抗cd40抗体およびその使用
|
TW201710286A
(zh)
|
2015-06-15 |
2017-03-16 |
艾伯維有限公司 |
抗vegf、pdgf及/或其受體之結合蛋白
|
CN107922497B
(zh)
|
2015-06-24 |
2022-04-12 |
詹森药业有限公司 |
抗vista抗体和片段
|
US11473073B2
(en)
|
2015-06-26 |
2022-10-18 |
Dupont Nutrition Biosciences Aps |
Aminopeptidases for protein hydrolyzates
|
RS61452B9
(sr)
|
2015-06-29 |
2021-12-31 |
Immunogen Inc |
Anti-cd123 antitela i njihovi konjugati i derivati
|
WO2017011275A1
(en)
|
2015-07-10 |
2017-01-19 |
Nersissian Aram M |
Factor viii protein compositions and methods of treating hemophilia a
|
CA2993009A1
(en)
|
2015-07-31 |
2017-02-09 |
Research Institute At Nationwide Children's Hospital |
Peptides and antibodies for the removal of biofilms
|
EP3331352B1
(en)
|
2015-08-06 |
2022-07-06 |
Pioneer Hi-Bred International, Inc. |
Plant derived insecticidal proteins and methods for their use
|
WO2017066719A2
(en)
|
2015-10-14 |
2017-04-20 |
Research Institute At Nationwide Children's Hospital |
Hu specific interfering agents
|
PL3374398T3
(pl)
|
2015-11-10 |
2020-08-24 |
Medimmune, Llc |
Cząsteczki wiążące swoiste dla ASCT2 i ich zastosowanie
|
WO2017105987A1
(en)
|
2015-12-18 |
2017-06-22 |
Pioneer Hi-Bred International, Inc. |
Insecticidal proteins and methods for their use
|
EP3405587A4
(en)
|
2015-12-23 |
2019-10-30 |
Moonshot Pharma LLC |
METHOD FOR TRIGGERING AN IMMUNE REACTION THROUGH READ THROUGH PROMOTION OF A PREVIOUS TERMINATION CODON
|
EP3413910A1
(en)
|
2016-02-12 |
2018-12-19 |
Janssen Pharmaceutica NV |
Anti-vista (b7h5) antibodies
|
BR112018015589A2
(pt)
|
2016-02-25 |
2019-10-01 |
Dupont Nutrition Biosci Aps |
método para produzir hidrolisado de proteína que emprega uma tripeptidil peptidase de aspergillus fumigatus
|
CN116284392A
(zh)
|
2016-03-10 |
2023-06-23 |
艾科赛扬制药股份有限公司 |
活化素2型受体结合蛋白及其用途
|
WO2017161206A1
(en)
|
2016-03-16 |
2017-09-21 |
Halozyme, Inc. |
Conjugates containing conditionally active antibodies or antigen-binding fragments thereof, and methods of use
|
CN109071653A
(zh)
|
2016-03-29 |
2018-12-21 |
詹森生物科技公司 |
用增加的抗-il12和/或-23抗体给药间隔治疗牛皮癣
|
WO2017175058A1
(en)
|
2016-04-07 |
2017-10-12 |
Janssen Pharmaceutica Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
EP3448391A4
(en)
|
2016-04-27 |
2019-12-18 |
AbbVie Inc. |
METHODS OF TREATING DISEASES IN WHICH IL-13 ACTIVITY IS HARMFUL WITH ANTI-IL-13 ANTIBODIES
|
US11008585B2
(en)
|
2016-05-04 |
2021-05-18 |
Pioneer Hi-Bred International, Inc. |
Insecticidal proteins and methods for their use
|
SG11201810678WA
(en)
|
2016-06-02 |
2018-12-28 |
Abbvie Inc |
Glucocorticoid receptor agonist and immunoconjugates thereof
|
CN109641962A
(zh)
|
2016-06-08 |
2019-04-16 |
艾伯维公司 |
抗b7-h3抗体和抗体药物偶联物
|
WO2017214335A1
(en)
|
2016-06-08 |
2017-12-14 |
Abbvie Inc. |
Anti-b7-h3 antibodies and antibody drug conjugates
|
JP2019526529A
(ja)
|
2016-06-08 |
2019-09-19 |
アッヴィ・インコーポレイテッド |
抗b7−h3抗体及び抗体薬物コンジュゲート
|
GB201610198D0
(en)
|
2016-06-10 |
2016-07-27 |
Ucb Biopharma Sprl |
Anti-ige antibodies
|
WO2017215790A1
(en)
|
2016-06-17 |
2017-12-21 |
National Hellenic Research Foundation |
Systems for recombinant protein production
|
WO2018005411A1
(en)
|
2016-07-01 |
2018-01-04 |
Pioneer Hi-Bred International, Inc. |
Insecticidal proteins from plants and methods for their use
|
JP2019534858A
(ja)
|
2016-09-09 |
2019-12-05 |
ジェネンテック, インコーポレイテッド |
Frizzledの選択的ペプチド阻害剤
|
JP2020500152A
(ja)
|
2016-09-30 |
2020-01-09 |
ヤンセン バイオテツク,インコーポレーテツド |
抗il23特異的抗体で乾癬を治療する安全かつ有効な方法
|
JP2019535015A
(ja)
|
2016-10-03 |
2019-12-05 |
アボット・ラボラトリーズAbbott Laboratories |
患者サンプルにおけるgfap状況を評価する改善された方法
|
US11021716B2
(en)
|
2016-11-01 |
2021-06-01 |
Pioneer Hi-Bred International, Inc. |
Insecticidal proteins and methods for their use
|
MX2019005661A
(es)
|
2016-11-16 |
2019-10-07 |
Janssen Biotech Inc |
Método para tratar la psoriasis con el anticuerpo específico anti-il23.
|
US10899842B2
(en)
|
2016-11-23 |
2021-01-26 |
Immunoah Therapeutics, Inc. |
4-1BB binding proteins and uses thereof
|
WO2018098363A2
(en)
|
2016-11-23 |
2018-05-31 |
Bioverativ Therapeutics Inc. |
Bispecific antibodies binding to coagulation factor ix and coagulation factor x
|
BR112019012339A2
(pt)
|
2016-12-14 |
2019-11-26 |
Pioneer Hi Bred Int |
polipeptídeo inseticida recombinante, composição, construto de dna, célula hospedeira, planta transgênica, método para inibir o crescimento ou extermínio de uma praga de inseto ou população de praga, polipeptídeo ipd093 quimérico e proteína de fusão
|
CA3046226A1
(en)
|
2016-12-22 |
2018-06-28 |
Pioneer Hi-Bred International, Inc. |
Insecticidal proteins and methods for their use
|
AU2018206560A1
(en)
|
2017-01-04 |
2019-07-18 |
Research Institute At Nationwide Children's Hospital |
Antibody fragments for the treatment of biofilm-related disorders
|
WO2018129029A1
(en)
|
2017-01-04 |
2018-07-12 |
Immunogen, Inc. |
Met antibodies and immunoconjugates and uses thereof
|
WO2018129078A1
(en)
|
2017-01-04 |
2018-07-12 |
Research Institute At Nationwide Children's Hospital |
Dnabii vaccines and antibodies with enhanced activity
|
US11390685B2
(en)
|
2017-01-06 |
2022-07-19 |
Biosion, Inc. |
ErbB2 antibodies and uses therefore
|
MX2019008989A
(es)
|
2017-01-30 |
2019-10-09 |
Janssen Biotech Inc |
Anticuerpos anti-tnf, composiciones y metodos para el tratamiento de la artritis psoriasica activa.
|
CN110418652A
(zh)
|
2017-02-07 |
2019-11-05 |
詹森生物科技公司 |
用于治疗活动性强直性脊柱炎的抗tnf抗体、组合物和方法
|
CA3052794A1
(en)
|
2017-02-08 |
2018-08-16 |
Pioneer Hi-Bred International, Inc. |
Insecticidal combinations of plant derived insecticidal proteins and methods for their use
|
WO2018152496A1
(en)
|
2017-02-17 |
2018-08-23 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Compositions and methods for the diagnosis and treatment of zika virus infection
|
EP3585445B1
(en)
|
2017-02-27 |
2024-02-07 |
Regeneron Pharmaceuticals, Inc. |
Humanized model of kidney and liver disorders
|
WO2018170178A1
(en)
|
2017-03-15 |
2018-09-20 |
Research Institute At Nationwide Children's Hospital |
Composition and methods for disruption of bacterial biofilms without accompanying inflammation
|
JP7346300B2
(ja)
|
2017-03-23 |
2023-09-19 |
アボット・ラボラトリーズ |
早期バイオマーカーであるユビキチンカルボキシ末端ヒドロラーゼl1を使用する、ヒト対象における外傷性脳損傷の程度の診断及び決定の一助となるための方法
|
US10877048B2
(en)
|
2017-04-15 |
2020-12-29 |
Abbott Laboratories |
Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury in a human subject using early biomarkers
|
SG11201909048TA
(en)
|
2017-04-21 |
2019-11-28 |
Genentech Inc |
Use of klk5 antagonists for treatment of a disease
|
WO2018200742A1
(en)
|
2017-04-25 |
2018-11-01 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Antibodies and methods for the diagnosis and treatment of epstein barr virus infection
|
WO2018200823A1
(en)
|
2017-04-28 |
2018-11-01 |
Abbott Laboratories |
Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury using early biomarkers on at least two samples from the same human subject
|
US10865238B1
(en)
|
2017-05-05 |
2020-12-15 |
Duke University |
Complement factor H antibodies
|
CA3063200A1
(en)
|
2017-05-11 |
2018-11-15 |
Pioneer Hi-Bred International, Inc. |
Insecticidal proteins and methods for their use
|
AU2018272054A1
(en)
|
2017-05-25 |
2019-09-26 |
Abbott Laboratories |
Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers
|
BR112019025313A2
(pt)
|
2017-05-30 |
2020-06-23 |
Abbott Laboratories |
Métodos para auxílio no diagnóstico e avaliação de uma lesão cerebral traumática leve em um indivíduo humano usando troponina cardíaca i
|
JP2020525434A
(ja)
|
2017-06-22 |
2020-08-27 |
ムーンショット ファーマ エルエルシー |
アンレキサノクス及び免疫調節剤を含む組成物で癌を治療する方法
|
CA3068041A1
(en)
|
2017-07-03 |
2019-01-10 |
Abbott Laboratories |
Improved methods for measuring ubiquitin carboxy-terminal hydrolase l1 levels in blood
|
EP3655430A1
(en)
|
2017-07-19 |
2020-05-27 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Antibodies and methods for the diagnosis and treatment of hepatitis b virus infection
|
WO2019025299A1
(en)
|
2017-07-31 |
2019-02-07 |
F. Hoffmann-La Roche Ag |
METHOD OF HUMANIZATION BASED ON THREE DIMENSIONAL STRUCTURE
|
TW201922780A
(zh)
|
2017-09-25 |
2019-06-16 |
美商健生生物科技公司 |
以抗il12/il23抗體治療狼瘡之安全且有效之方法
|
KR20210027230A
(ko)
|
2017-10-04 |
2021-03-10 |
옵코 파마슈티칼스, 엘엘씨 |
암의 개인 맞춤형 치료에 관한 물품 및 방법
|
WO2019075090A1
(en)
|
2017-10-10 |
2019-04-18 |
Tilos Therapeutics, Inc. |
ANTI-LAP ANTIBODIES AND USES THEREOF
|
CA3082365A1
(en)
|
2017-11-09 |
2019-05-16 |
Pinteon Therapeutics Inc. |
Methods and compositions for the generation and use of humanized conformation-specific phosphorylated tau antibodies
|
CN111094983A
(zh)
|
2017-12-09 |
2020-05-01 |
雅培实验室 |
使用胶质细胞原纤维酸性蛋白(gfap)和/或泛素羧基末端水解酶l1(uch-l1)帮助诊断和评价已遭受骨科损伤并已遭受或可能已遭受头部损伤诸如轻度创伤性脑损伤(tbi)的患者的方法
|
CA3067055A1
(en)
|
2017-12-09 |
2019-06-13 |
Abbott Laboratories |
Methods for aiding in diagnosing and evaluating a traumatic brain injury in a human subject using a combination of gfap and uch-l1
|
TW201929907A
(zh)
|
2017-12-22 |
2019-08-01 |
美商建南德克公司 |
Pilra結合劑用於治療疾病之用途
|
BR112020010430A2
(pt)
|
2017-12-29 |
2020-11-24 |
Abbott Laboratories |
biomarcadores e métodos inovadores para diagnosticar e avaliar lesão cerebral traumática
|
WO2019150309A1
(en)
|
2018-02-02 |
2019-08-08 |
Hammack Scott |
Modulators of gpr68 and uses thereof for treating and preventing diseases
|
BR112020016400A2
(pt)
|
2018-02-14 |
2020-12-15 |
Viela Bio, Inc. |
Anticorpos para o ligante do receptor de tirosina cinase 3 similar ao sarcoma felino de mcdonough (fms) (flt3l) e suas utilizações para o tratamento de doenças autoimunes e inflamatórias
|
EP3762015A4
(en)
|
2018-03-05 |
2022-04-27 |
Janssen Biotech, Inc. |
METHODS OF TREATING CROHN'S DISEASE WITH SPECIFIC ANTI-IL23 ANTIBODY
|
EP3765499A1
(en)
|
2018-03-12 |
2021-01-20 |
Zoetis Services LLC |
Anti-ngf antibodies and methods thereof
|
WO2019213619A1
(en)
|
2018-05-04 |
2019-11-07 |
Abbott Laboratories |
Hbv diagnostic, prognostic, and therapeutic methods and products
|
US11708571B2
(en)
|
2018-05-17 |
2023-07-25 |
Bp Corporation North America Inc. |
Production of 2-keto-3-deoxy-d-gluconic acid in filamentous fungi
|
WO2019244107A1
(en)
|
2018-06-21 |
2019-12-26 |
Daiichi Sankyo Company, Limited |
Compositions including cd3 antigen binding fragments and uses thereof
|
WO2020014306A1
(en)
|
2018-07-10 |
2020-01-16 |
Immunogen, Inc. |
Met antibodies and immunoconjugates and uses thereof
|
JP2021530697A
(ja)
|
2018-07-18 |
2021-11-11 |
ヤンセン バイオテツク,インコーポレーテツド |
抗il23特異的抗体で治療した後の持続応答予測因子
|
US11548938B2
(en)
|
2018-08-21 |
2023-01-10 |
Quidel Corporation |
DbpA antibodies and uses thereof
|
EP3847262A1
(en)
|
2018-09-07 |
2021-07-14 |
Basf Plant Science Company GmbH |
Improved method for the production of high levels of pufa in plants
|
US20220025391A1
(en)
|
2018-09-07 |
2022-01-27 |
Basf Plant Science Company Gmbh |
Improved method for the production of high levels of pufa in plants
|
AU2019334672A1
(en)
|
2018-09-07 |
2021-03-25 |
Basf Plant Science Company Gmbh |
Improved method for the production of high levels of PUFA in plants
|
BR112021005467A2
(pt)
|
2018-09-24 |
2021-06-22 |
Janssen Biotech, Inc. |
método seguro e eficaz para tratar colite ulcerativa com anticorpo anti-il12/il23
|
JP2022512580A
(ja)
|
2018-10-05 |
2022-02-07 |
リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル |
細菌バイオフィルムの酵素的破壊のための組成物および方法
|
US11130802B2
(en)
|
2018-10-10 |
2021-09-28 |
Tilos Therapeutics, Inc. |
Anti-lap antibody variants
|
CN113395979A
(zh)
|
2018-11-20 |
2021-09-14 |
詹森生物科技公司 |
用抗il-23特异性抗体治疗银屑病的安全且有效的方法
|
WO2020106358A1
(en)
|
2018-11-20 |
2020-05-28 |
Takeda Vaccines, Inc. |
Novel anti-zika virus antibodies and uses thereof
|
MA54562A
(fr)
|
2018-12-18 |
2021-10-27 |
Janssen Biotech Inc |
Méthode sûre et efficace de traitement du lupus avec un anticorps anti-il12/il23
|
EP3897117A1
(en)
|
2018-12-21 |
2021-10-27 |
Compass Therapeutics LLC |
Transgenic mouse expressing common human light chain
|
AU2020208828A1
(en)
|
2019-01-15 |
2021-08-05 |
Janssen Biotech, Inc. |
Anti-TNF antibody compositions and methods for the treatment of juvenile idiopathic arthritis
|
EA202192038A1
(ru)
|
2019-01-23 |
2021-10-05 |
Янссен Байотек, Инк. |
Композиции антител к фно для применения в способах лечения псориатического артрита
|
EP3938391A1
(en)
|
2019-03-14 |
2022-01-19 |
Janssen Biotech, Inc. |
Methods for producing anti-tnf antibody compositions
|
EA202192508A1
(ru)
|
2019-03-14 |
2022-03-29 |
Янссен Байотек, Инк. |
Способы получения композиций антитела к фно
|
CA3133381A1
(en)
|
2019-03-14 |
2020-09-17 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-tnf antibody compositions
|
CA3133395A1
(en)
|
2019-03-14 |
2020-09-17 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-il12/il23 antibody compositions
|
KR20210141583A
(ko)
|
2019-03-18 |
2021-11-23 |
얀센 바이오테크 인코포레이티드 |
항-il-12/il-23 항체를 사용한 소아 대상의 건선 치료 방법
|
CN113795514A
(zh)
|
2019-05-09 |
2021-12-14 |
豪夫迈·罗氏有限公司 |
制备抗体的方法
|
US11780911B2
(en)
|
2019-05-23 |
2023-10-10 |
Janssen Biotech, Inc. |
Method of treating inflammatory bowel disease with a combination therapy of antibodies to IL-23 and TNF alpha
|
KR20220029593A
(ko)
|
2019-06-03 |
2022-03-08 |
얀센 바이오테크 인코포레이티드 |
건선성 관절염의 치료를 위한 항-tnf 항체 조성물, 및 방법
|
JP2022535534A
(ja)
|
2019-06-03 |
2022-08-09 |
ヤンセン バイオテツク,インコーポレーテツド |
活動性強直性脊椎炎を治療するための抗tnf抗体、組成物、及び方法
|
BR112021026890A2
(pt)
|
2019-07-08 |
2022-03-15 |
Res Inst Nationwide Childrens Hospital |
Composições de anticorpo para interromper biofilmes
|
WO2021028752A1
(en)
|
2019-08-15 |
2021-02-18 |
Janssen Biotech, Inc. |
Anti-tfn antibodies for treating type i diabetes
|
US20210188971A1
(en)
|
2019-12-19 |
2021-06-24 |
Quidel Corporation |
Monoclonal antibody fusions
|
BR112022011895A2
(pt)
|
2019-12-20 |
2022-09-06 |
Basf Se |
Diminuição da toxidez de terpenos e aumento da produção potencial em microrganismos
|
AU2021215936A1
(en)
|
2020-02-05 |
2022-08-25 |
Larimar Therapeutics, Inc. |
TAT peptide binding proteins and uses thereof
|
EP4132971A1
(en)
|
2020-04-09 |
2023-02-15 |
Merck Sharp & Dohme LLC |
Affinity matured anti-lap antibodies and uses thereof
|
EP4136459A1
(en)
|
2020-04-13 |
2023-02-22 |
Abbott Laboratories |
Methods, complexes and kits for detecting or determining an amount of a ss-coronavirus antibody in a sample
|
US20210338833A1
(en)
|
2020-05-01 |
2021-11-04 |
Massachusetts Institute Of Technology |
Chimeric antigen receptor-targeting ligands and uses thereof
|
WO2021221783A1
(en)
|
2020-05-01 |
2021-11-04 |
Massachusetts Institute Of Technology |
Methods for identifying chimeric antigen receptor-targeting ligands and uses thereof
|
WO2021245064A1
(en)
|
2020-06-04 |
2021-12-09 |
Isobionics B.V. |
Synthetic santalene synthases
|
BR112022027035A2
(pt)
|
2020-07-14 |
2023-04-11 |
Pioneer Hi Bred Int |
Proteínas inseticidas e métodos para uso das mesmas
|
US20220043000A1
(en)
|
2020-08-04 |
2022-02-10 |
Abbott Laboratories |
Methods and kits for detecting sars-cov-2 protein in a sample
|
EP4193151A1
(en)
|
2020-08-04 |
2023-06-14 |
Abbott Rapid Diagnostics International Unlimited Company |
Assays for detecting sars-cov-2
|
BR112023004415A2
(pt)
|
2020-09-11 |
2023-05-09 |
Medimmune Ltd |
Moléculas terapêuticas de ligação a b7-h4
|
EP4211663A2
(en)
|
2020-09-12 |
2023-07-19 |
MedImmune Limited |
A scoring method for an anti-b7h4 antibody-drug conjugate therapy
|
WO2023102384A1
(en)
|
2021-11-30 |
2023-06-08 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
|
CA3198161A1
(en)
|
2020-12-01 |
2022-06-09 |
Beth MCQUISTON |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
|
EP4015626A1
(en)
|
2020-12-18 |
2022-06-22 |
Isobionics B.V. |
Enzymes and methods for fermentative production of monoterpene esters
|
EP4271998A1
(en)
|
2020-12-30 |
2023-11-08 |
Abbott Laboratories |
Methods for determining sars-cov-2 antigen and anti-sars-cov-2 antibody in a sample
|
KR20230146522A
(ko)
|
2021-01-13 |
2023-10-19 |
메모리얼 슬로안 케터링 캔서 센터 |
항-dll3 항체-약물 접합체
|
CA3204628A1
(en)
|
2021-01-13 |
2022-07-21 |
John T. POIRIER |
Antibody-pyrrolobenzodiazepine derivative conjugate
|
UY39610A
(es)
|
2021-01-20 |
2022-08-31 |
Abbvie Inc |
Conjugados anticuerpo-fármaco anti-egfr
|
EP4305062A1
(en)
|
2021-03-12 |
2024-01-17 |
Janssen Biotech, Inc. |
Method of treating psoriatic arthritis patients with inadequate response to tnf therapy with anti-il23 specific antibody
|
IL305802A
(en)
|
2021-03-12 |
2023-11-01 |
Janssen Biotech Inc |
A safe and effective method for the treatment of rheumatoid arthritis with a specific anti-IL23 antibody
|
JP2024511078A
(ja)
|
2021-03-17 |
2024-03-12 |
レセプトス エルエルシー |
抗il-13抗体を用いてアトピー性皮膚炎を処置する方法
|
CA3212630A1
(en)
|
2021-03-18 |
2022-09-22 |
Medimmune Limited |
Therapeutic binding molecules
|
EP4337689A1
(en)
|
2021-05-12 |
2024-03-20 |
Applied Biomedical Science Institute |
Binding polypeptides against sars cov-2 and uses thereof
|
CA3216320A1
(en)
|
2021-05-18 |
2022-11-24 |
Abbott Laboratories |
Methods of evaluating brain injury in a pediatric subject
|
US20220372129A1
(en)
|
2021-05-20 |
2022-11-24 |
Janssen Biotech, Inc. |
Method of Treating Inflammatory Bowel Disease with a Combination Therapy of Antibodies to IL-23 and TNF Alpha
|
CA3222291A1
(en)
|
2021-06-14 |
2022-12-22 |
Jaime MARINO |
Methods of diagnosing or aiding in diagnosis of brain injury caused by acoustic energy, electromagnetic energy, an over pressurization wave, and/or blast wind
|
KR20240034215A
(ko)
|
2021-07-09 |
2024-03-13 |
얀센 바이오테크 인코포레이티드 |
항-il12/il23 항체 조성물을 생산하기 위한 제조 방법
|
US20230040065A1
(en)
|
2021-07-09 |
2023-02-09 |
Janssen Biotech, Inc. |
Manufacturing Methods for Producing Anti-TNF Antibody Compositions
|
WO2023281463A1
(en)
|
2021-07-09 |
2023-01-12 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-tnf antibody compositions
|
CN117795087A
(zh)
|
2021-08-02 |
2024-03-29 |
巴斯夫欧洲公司 |
用紫罗兰亚基乙烷合酶进行的芳香化合物的新颖生产
|
US11807685B2
(en)
|
2021-08-05 |
2023-11-07 |
The Uab Research Foundation |
Anti-CD47 antibody and uses thereof
|
WO2023028186A1
(en)
|
2021-08-27 |
2023-03-02 |
Abbott Laboratories |
Methods for detecting immunoglobulin g, subclass 4 (igg4) in a biological sample
|
AU2022339759A1
(en)
|
2021-08-31 |
2024-03-07 |
Abbott Laboratories |
Methods and systems of diagnosing brain injury
|
WO2023056268A1
(en)
|
2021-09-30 |
2023-04-06 |
Abbott Laboratories |
Methods and systems of diagnosing brain injury
|
WO2023073615A1
(en)
|
2021-10-29 |
2023-05-04 |
Janssen Biotech, Inc. |
Methods of treating crohn's disease with anti-il23 specific antibody
|
US20230151087A1
(en)
|
2021-11-15 |
2023-05-18 |
Janssen Biotech, Inc. |
Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody
|
US20230159633A1
(en)
|
2021-11-23 |
2023-05-25 |
Janssen Biotech, Inc. |
Method of Treating Ulcerative Colitis with Anti-IL23 Specific Antibody
|
WO2023114978A1
(en)
|
2021-12-17 |
2023-06-22 |
Abbott Laboratories |
Systems and methods for determining uch-l1, gfap, and other biomarkers in blood samples
|
US20230213536A1
(en)
|
2021-12-28 |
2023-07-06 |
Abbott Laboratories |
Use of biomarkers to determine sub-acute traumatic brain injury (tbi) in a subject having received a head computerized tomography (ct) scan that is negative for a tbi or no head ct scan
|
WO2023150652A1
(en)
|
2022-02-04 |
2023-08-10 |
Abbott Laboratories |
Lateral flow methods, assays, and devices for detecting the presence or measuring the amount of ubiquitin carboxy-terminal hydrolase l1 and/or glial fibrillary acidic protein in a sample
|
TW202348252A
(zh)
|
2022-02-16 |
2023-12-16 |
英商梅迪繆思有限公司 |
用治療性結合分子治療癌症的組合療法
|
WO2023187707A1
(en)
|
2022-03-30 |
2023-10-05 |
Janssen Biotech, Inc. |
Method of treating mild to moderate psoriasis with il-23 specific antibody
|
WO2023223265A1
(en)
|
2022-05-18 |
2023-11-23 |
Janssen Biotech, Inc. |
Method for evaluating and treating psoriatic arthritis with il23 antibody
|
WO2024006876A1
(en)
|
2022-06-29 |
2024-01-04 |
Abbott Laboratories |
Magnetic point-of-care systems and assays for determining gfap in biological samples
|
WO2024059708A1
(en)
|
2022-09-15 |
2024-03-21 |
Abbott Laboratories |
Biomarkers and methods for differentiating between mild and supermild traumatic brain injury
|
WO2024059692A1
(en)
|
2022-09-15 |
2024-03-21 |
Abbott Laboratories |
Hbv diagnostic, prognostic, and therapeutic methods and products
|